exv99w2

1. Income from employment or operation of business

State the gross amount of income the debtor has received from employment, trade, or profession, or from operation of the debtor’s business, including part-time activities either as an employee or in independent trade or business, from the beginning of this calendar year to the date this case was commenced. State also the gross amounts received during the two years immediately preceding this calendar year. (A debtor that maintains, or has maintained, financial records on the basis of a fiscal rather than a calendar year may report fiscal year income. Identify the beginning and ending dates of the debtor’s fiscal year.) If a joint petition is filed, state income for each spouse separately. (Married debtors filing under chapter 12 or chapter 13 must state income of both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)

AMOUNT $167,539

SOURCE Service Contract Revenue

IN THE UNITED STATES BANKRUPTCY COURT
FOR THE DISTRICT OF DELAWARE



	x
	:	Chapter 11
In re:	:
	:	Case No. 09-11091 (CSS)
VERMILLION, INC.,²	:
	:
Debtor.	:
	:
	:
	:
	x

STATEMENT OF FINANCIAL AFFAIRS AND SCHEDULES OF ASSETS
LIABILITIES DECLARATION UNDER PENALTY OF PERJURY
OF GAIL S. PAGE, ON BEHALF OF THE COMPANY

I, Ms. Gail S. Page, Executive Chair of the Board of Directors of Vermillion, Inc., the above-captioned debtor and debtor-in-possession (the “Debtor”), declare under penalty of perjury that I have reviewed the Debtor’s Statement of Financial Affairs, Summary of Schedules, Schedule A, B, D, E, F, G, and H (collectively, the “Schedules”) and the Global Notes and Statement of Limitations, Methodology and Disclaimer Regarding Debtor’s Statements of Financial Affairs with Schedules, and that they are true and correct to the best of my knowledge, information, and belief.

Although every effort has been taken to make the Statement of Financial Affairs and Schedules of Assets and Liabilities accurate and complete, because of the magnitude and complexity of the task, inadvertent errors or omissions may exist.

Date: June 11, 2009


		Ms. Gail S. Page
		Executive Chair of the Board of Directors
		Vermillion, Inc.


²		The address of the Debtor’s principal executive offices is 47350 Fremont Blvd., Fremont, California 94538. The Debtor’s EIN is 33-0595156.

IN THE UNITED STATES BANKRUPTCY COURT
FOR THE DISTRICT OF DELAWARE



	x
	:	Chapter 11
In re:	:
	:	Case No. 09-11091 (CSS)
VERMILLION, INC.,	:
	:
Debtor.	:
	:
	:
	:
	x

GLOBAL NOTES AND STATEMENT OF LIMITATIONS, METHODOLOGY
AND DISCLAIMER REGARDING DEBTOR’S STATEMENTS OF FINANCIAL
AFFAIRS WITH SCHEDULES¹

The Schedules of Assets and Liabilities and Statements of Financial Affairs (the “Schedules and Statements”) filed herewith by Vermillion, Inc. (“Vermillion”), the above-captioned debtor and debtor-in-possession (the “Debtor”) were prepared pursuant to section 521 of 11 U.S.C. §§ 101-1532 (as amended and applicable to this bankruptcy case, the “Bankruptcy Code”) and Rule 1007 of the Federal Rules of Bankruptcy Procedure (the “Bankruptcy Rules”) by management of the Debtor and are unaudited. While the Debtor’s management has made every effort to ensure that the Schedules and Statements are accurate and complete based on information that was available at the time of preparation, inadvertent errors or omissions may have occurred. The Schedules and Statements remain subject to further review and verification by the Debtor. Subsequent information may result in material changes in financial and other data contained in the Schedules and Statements. Except as noted in the Schedules and Statements, all asset and liability data is reported as of the close of business on March 30, 2009. The Debtor has used its best efforts to compile the information set forth in the Schedules and Statements from its books and records maintained in the ordinary course of its business. The Debtor reserves its right to amend its Schedules and Statements from time to time as may be necessary or appropriate. These Global Notes and Statement of Limitations, Methodology and Disclaimer Regarding Debtor’s Statements of Financial Affairs with Schedules (the “Global Notes”) are incorporated by reference in, and comprise an integral part of, the Schedules and Statements, and should be referred to and reviewed in connection with any review of the Schedules and Statements.


¹		A Statement of Financial Affairs and Schedule of Assets of Liabilities for the Debtor begins immediately after these Global Notes.

1. Description of the Cases. On March 30, 2009 (the “Petition Date”), the Debtor filed its voluntary petition with the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) for reorganization under chapter 11 of the Bankruptcy Code under case numbers 09-11091 (CSS) and an order for relief was entered by the Bankruptcy Court. The Debtor is currently operating its business as a debtor in possession under the Bankruptcy Code.

2. Basis of Presentation. For financial reporting purposes, the Debtor prepares consolidated financial statements, which include financial information for certain of the Debtor’s non-debtor subsidiaries. The Schedules and Statements are unaudited and reflect the Debtor’s best efforts to report the assets and liabilities of the Debtor on an unconsolidated basis. These Schedules and Statements neither purport to represent financial statements prepared in accordance with Generally Accepted Accounting Principles in the United States (“GAAP”), nor are they intended to fully reconcile to the financial statements.

3. Summary of Significant Reporting Policies. The Schedules and Statements have been signed by Ms. Gail S. Page, Executive Chair of the Board of Directors of Vermillion. In reviewing and signing the Schedules and Statements, Ms Page has necessarily relied upon the efforts, statements and representations of the accounting and non-accounting personnel located at Vermillion’s headquarters. Ms. Page has not (and could not have) personally verified the accuracy of each such statement and representation, including statements and representations concerning amounts owed to creditors.

The Debtor made its best effort to report asset, liability, disbursement, and other information on the appropriate Schedules and Statements. However, the following qualifications and limitations apply to the Schedules and Statements and the Debtor has adopted the following conventions in the preparation of the Schedules and Statements:

(a) Reporting Date. Assets reported in the Debtor’s Schedules and Statements are prepared as of the close of business on March 30, 2009, unless otherwise noted. Liabilities are reported in the Debtor’s Schedules and Statements as of the close of business on March 30, 2009.

(b) Book Value. Each asset and liability of the Debtor is shown on the basis of the book value of the asset or liability in the Debtor’s accounting books and records, unless otherwise noted, rather than the current market values, of such interests in property and/or liabilities.

(c) Intellectual Property Rights. Inclusion of certain intellectual property shall not be construed as an admission that such intellectual property rights have not been abandoned, have not been terminated or otherwise expired by their terms, or have not been assigned or otherwise transferred pursuant to a sale, acquisition, or other transaction. Accordingly, the Debtor reserves all of its rights with respect to the legal status of such intellectual property rights.

(d) Causes of Action. The Debtor has not set forth all causes of action against all third parties as assets in their Schedules and Statements. The Debtor reserves all of its

rights with respect to any causes of action that it may have, and neither these Global Notes nor the Schedules and Statements shall be deemed a waiver of any such causes of action.

(e) Executory Contracts. The Debtor has not set forth executory contracts as assets in their Schedules and Statements. The Debtor’s executory contracts have been set forth in Schedule G.

(f) Property and equipment — owned. Unless otherwise noted, owned property and equipment are stated as net book value. The estimated useful lives for the Debtor’s assets are up to eight (8) years for other fixtures and equipment and leasehold improvements are depreciated over a eight (8) year period or the life of the lease, whichever is less. The leases are identified in the Debtor’s Schedule G of Executory Contracts. For tax reporting purposes, all assets were recorded using straight line methods of depreciation. Inasmuch as the Debtor calculates depreciation and amortization monthly, the Schedules and Statements reflect monthly depreciation and amortization through March 30, 2009.

(g) Property and equipment — leased. In the ordinary course of its business, the Debtor leases equipment and computer hardware and software from certain third-party lessors. Any such leases are set forth in the Schedules and Statements. Nothing in the Schedules and Statements is or shall be construed as an admission or determination as to the legal status of any lease (including whether any lease is a true lease or a financing arrangement), and the Debtor reserves all rights with respect to any of such issues.

(h) Payments to Creditors and Insiders. On Statement of Financial Affairs 3c and 23, the Debtor has not scheduled payments made to employees who may be deemed officers where the employees function in a purely ministerial role and have no material inside information.

(i) Interests in Subsidiaries and Affiliates. Vermillion owns directly or indirectly eleven subsidiaries and/or affiliates. Equity interests in subsidiaries and affiliates primarily arise from common stock ownership or partnership interests. The Debtor’s “Schedule B-Personal Property” lists the Debtor’s ownership interests, if any, in subsidiaries and affiliates. For purposes of these Schedules and Statements, the Debtor has listed the value of some ownership interests as undetermined because the fair market value of such stock or interests is dependent on numerous variables and factors and may differ significantly from the net book value.

(j) Financial Statements. Vermillion is a publicly traded corporation whose common shares were traded as of the Petition Date on the OTC Bulletin Board under the symbol “VRML.” Prior to the Petition Date, Vermillion publicly filed periodic reports with the United States Securities & Exchange Commission.

(k) Schedule D:

(i) Except as otherwise agreed pursuant to a stipulation or agreed order or any other order entered by the Bankruptcy Court, the Debtor reserves its rights to dispute or challenge the validity, perfection, or immunity from avoidance of any lien purported to be granted or perfected in any specific asset to a secured creditor listed on Schedule D of the

Schedules and Statements. Moreover, although the Debtor has scheduled claims of certain creditors as secured claims, the Debtor reserves all rights to dispute or challenge the secured nature of any such creditor’s claim or the characterization of the structure of any such transaction, or any document or instrument related to such creditor’s claim.

(ii) No claim set forth on Schedule D of the Schedules and Statements is intended to acknowledge claims of creditors that are otherwise satisfied or discharged by other entities. The descriptions provided in Schedule D are intended only to be a summary. Reference to the applicable loan agreements and related documents is necessary for a complete description of the collateral and the nature, extent, and priority of any liens. Nothing in the Global Notes or the Schedules and Statements shall be deemed a modification or interpretation of the terms of such agreements. Holders of secured claims by virtue of holding setoff rights against the Debtor are not included on Schedule D. To the extent that the Debtor is a party to capital leases, the Debtor has treated those leases as executory contracts, which may be shown on Schedule G. However, the Debtor reserves its rights to assert that such capital leases are secured financings, rather than unexpired leases.

(l) Schedule F. No claim set forth on Schedule F of the Schedules and Statements is intended to acknowledge claims of creditors that are otherwise satisfied or discharged by other entities. The descriptions provided in Schedule F are intended only to be a summary. Nothing in the Global Notes or the Schedules and Statements shall be deemed a modification or interpretation of the terms of such agreements. The claims of individual creditors for, among other things, merchandise, goods, services, or taxes are listed at the amounts listed on the Debtor’s books and records and may not reflect credits or allowances due from such creditor. The Debtor reserves all of its rights respecting such credits and allowances. The dollar amounts listed may be exclusive of contingent and unliquidated amounts. The Debtor expressly incorporates by reference into Schedule F all parties to pending and potential pending litigation listed in the Debtor’s Statements as contingent, unliquidated, and disputed claims to the extent not already listed on Schedule F. All parties to executory contracts, including those listed on Schedule G, are holders of contingent and unliquidated unsecured claims arising from (i) obligations under those executory contracts and/or (ii) rejection damages in the event that such executory contract is rejected. Not all such claims are duplicated on Schedule F.

(m) Schedule G:

(i) While every effort has been made to ensure the accuracy of the Schedule of Executory Contracts, inadvertent errors or omissions may have occurred. The Debtor hereby reserves all of its rights to dispute the validity, status, or enforceability of any contracts, agreements, or leases set forth in Schedule G and to amend or supplement such Schedule as necessary.

(ii) The contracts, agreements, and leases listed on Schedule G may have expired or may have been modified, amended, or supplemented from time to time by various amendments, restatements, waivers, estoppel certificates, letters, and other documents, instruments, and agreements that may not be listed therein. Certain of the real property leases listed on Schedule G may contain renewal options, guarantees of payment, options to purchase, rights of first refusal, rights to lease additional space, and other miscellaneous rights. Such

rights, powers, duties, and obligations are not set forth on Schedule G. Certain of the executory agreements may not have been memorialized and could be subject to dispute. Schedule G does not include stand alone purchase orders for goods or equipment or nondisclosure agreements. Additionally, the Debtor may be parties to various other agreements concerning real property, such as easements, rights of way, subordination, non-disturbance and attornment agreements, supplemental agreements, amendments/letter agreements, title documents, consents, site plans, maps, and other miscellaneous agreements. Such documents are not set forth in Schedule G. Certain of the agreements listed on Schedule G may be in the nature of conditional sales agreements or secured financings.

(iii) The presence of a contract or agreement on this schedule does not constitute an admission that such contract or agreement is an executory contract or unexpired lease. The Debtor reserves all of its rights, claims, and causes of action with respect to the contracts and agreements listed on these Schedules.

(n) Statement of Financial Affairs. Both questions 3c and 23 in the statement of financial affairs request information regarding payments to insiders. The Debtor has listed payroll related payments and loan repayments to its insiders in response to question 3c and 23.

4. Employee Claims. The Bankruptcy Court entered an order (the “401K Order”) granting authority to the Debtor to pay prepetition obligations owed in connection with the Debtor’s 401K Plan. Pursuant to such 401K Order, the Debtor believes that any employee claims for prepetition amounts owed in connection with the 401K plan either have been satisfied or are in the process of being satisfied. The Debtor believes that no other prepetition employee wage, salary, benefit, or other employee claims are outstanding. Accordingly, employee claims for amounts owing as of the end of the day on March 30, 2009, that have been paid or that are intended to be paid have not been included in the Schedules and Statements. The Debtor has listed its employees on Schedules E and/or F as having unliquidated claims that cover accrued vacation and/or bonuses.

5. Disputed, Contingent, and/or Unliquidated Claims. Schedules D, E, and F permit the Debtor to designate a claim as disputed, contingent, and/or unliquidated. A failure to designate a claim on any of these schedules as disputed, contingent, and/or unliquidated does not constitute an admission that such claim is not subject to objection. The Debtor reserves the right to dispute, or assert offsets or defenses to any claim reflected on these Schedules as to nature, amount, liability, or status or to otherwise subsequently designate any claim as disputed, contingent, or unliquidated.

6. Insurance. Vermillion maintains general liability insurance policies, and various other insurance policies, on behalf of the Debtor. A listing of all such insurance policies is set forth on Schedule G.

B7 (Official Form 7) (12/07)

United States Bankruptcy Court
District of Delaware


In re	Vermillion, Inc.		Case No.	09-11091

		Debtor(s)	Chapter	11

STATEMENT OF FINANCIAL AFFAIRS

This statement is to be completed by every debtor. Spouses filing a joint petition may file a single statement on which the information for both spouses is combined. If the case is filed under chapter 12 or chapter 13, a married debtor must furnish information for both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed. An individual debtor engaged in business as a sole proprietor, partner, family farmer, or self-employed professional, should provide the information requested on this statement concerning all such activities as well as the individual’s personal affairs. To indicate payments, transfers and the like to minor children, state the child’s initials and the name and address of the child’s parent or guardian, such as “A.B., a minor child, by John Doe, guardian.” Do not disclose the child’s name. See, 11 U.S.C. § 112; Fed. R. Bankr. P. 1007(m).

Questions 1 — 18 are to be completed by all debtors. Debtors that are or have been in business, as defined below, also must complete Questions 19 — 25. If the answer to an applicable question is “None,” mark the box labeled “None.” If additional space is needed for the answer to any question, use and attach a separate sheet properly identified with the case name, case number (if known), and the number of the question.

DEFINITIONS

“In business.” A debtor is “in business” for the purpose of this form if the debtor is a corporation or partnership. An individual debtor is “in business” for the purpose of this form if the debtor is or has been, within six years immediately preceding the filing of this bankruptcy case, any of the following: an officer, director, managing executive, or owner of 5 percent or more of the voting or equity securities of a corporation; a partner, other than a limited partner, of a partnership; a sole proprietor or self-employed full-time or part-time. An individual debtor also may be “in business” for the purpose of this form if the debtor engages in a trade, business, or other activity, other than as an employee, to supplement income from the debtor’s primary employment.

“Insider.” The term “insider” includes but is not limited to: relatives of the debtor; general partners of the debtor and their relatives; corporations of which the debtor is an officer, director, or person in control; officers, directors, and any owner of 5 percent or more of the voting or equity securities of a corporate debtor and their relatives; affiliates of the debtor and insiders of such affiliates; any managing agent of the debtor. 11 U.S.C. § 101.


Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


NAME AND ADDRESS	DATES OF		AMOUNT STILL
OF CREDITOR	PAYMENTS	AMOUNT PAID	OWING


		b. Debtor whose debts are not primarily consumer debts: List each payment or other transfer to any creditor made within 90 days immediately preceding the commencement of the case unless the aggregate value of all property that constitutes or is affected by such transfer is less than $5,475. If the debtor is an individual, indicate with an asterisk (*) any payments that were made to a creditor on account of a domestic support obligation or as part of an alternative repayment schedule under a plan by an approved nonprofit budgeting and creditor counseling agency. (Married debtors filing under chapter 12 or chapter 13 must include payments by either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)


		AMOUNT
	DATES OF	PAID OR
NAME AND ADDRESS OF CREDITOR	PAYMENTS/	VALUE OF	AMOUNT STILL
See attached file — Form 7, question 3-b	TRANSFERS	TRANSFERS	OWING


		c. All debtors: List all payments made within one year immediately preceding the commencement of this case to or for the benefit of creditors who are or were insiders. (Married debtors filing under chapter 12 or chapter 13 must include payments by either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)


None þ		b. Describe all property that has been attached, garnished or seized under any legal or equitable process within one year immediately preceding the commencement of this case. (Married debtors filing under chapter 12 or chapter 13 must include information concerning property of either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)


NAME AND ADDRESS OF PERSON FOR WHOSE BENEFIT PROPERTY WAS SEIZED		DATE OF SEIZURE		DESCRIPTION AND VALUE OF PROPERTY


NAME AND ADDRESS OF CREDITOR OR SELLER		DATE OF REPOSSESSION, FORECLOSURE SALE, TRANSFER OR RETURN		DESCRIPTION AND VALUE OF PROPERTY


Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


		6. Assignments and receiverships

None þ		a. Describe any assignment of property for the benefit of creditors made within 120 days immediately preceding the commencement of this case. (Married debtors filing under chapter 12 or chapter 13 must include any assignment by either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)


	DATE OF
NAME AND ADDRESS OF ASSIGNEE	ASSIGNMENT	TERMS OF ASSIGNMENT OR SETTLEMENT


None þ		b. List all property which has been in the hands of a custodian, receiver, or court-appointed official within one year immediately preceding the commencement of this case. (Married debtors filing under chapter 12 or chapter 13 must include information concerning property of either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)


		7. Gifts

None þ		List all gifts or charitable contributions made within one year immediately preceding the commencement of this case except ordinary and usual gifts to family members aggregating less than $200 in value per individual family member and charitable contributions aggregating less than $100 per recipient. (Married debtors filing under chapter 12 or chapter 13 must include gifts or contributions by either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)


		8. Losses

None þ		List all losses from fire, theft, other casualty or gambling within one year immediately preceding the commencement of this case or since the commencement of this case. (Married debtors filing under chapter 12 or chapter 13 must include losses by either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)


	DESCRIPTION OF CIRCUMSTANCES AND, IF
DESCRIPTION AND VALUE	LOSS WAS COVERED IN WHOLE OR IN PART
OF PROPERTY	BY INSURANCE, GIVE PARTICULARS	DATE OF LOSS


		9. Payments related to debt counseling or bankruptcy

		List all payments made or property transferred by or on behalf of the debtor to any persons, including attorneys, for consultation concerning debt consolidation, relief under the bankruptcy law or preparation of the petition in bankruptcy within one year immediately preceding the commencement of this case.


	DATE OF PAYMENT,		AMOUNT OF MONEY
NAME AND ADDRESS	NAME OF PAYOR IF OTHER		OR DESCRIPTION AND VALUE
OF PAYEE	THAN DEBTOR		OF PROPERTY
Paul, Hastings, Janofsky		3/25/09	$	170,000.00
Womble Carlyle Sandridge & Rice, PLLC		3/27/09	$	30,000.00


		10. Other transfers

None þ		a. List all other property, other than property transferred in the ordinary course of the business or financial affairs of the debtor, transferred either absolutely or as security within two years immediately preceding the commencement of this case. (Married debtors filing under chapter 12 or chapter 13 must include transfers by either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)


NAME AND ADDRESS OF TRANSFEREE,		DESCRIBE PROPERTY TRANSFERRED
RELATIONSHIP TO DEBTOR	DATE	AND VALUE RECEIVED



Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


None þ		b. List all property transferred by the debtor within ten years immediately preceding the commencement of this case to a self-settled trust or similar device of which the debtor is a beneficiary.


		AMOUNT OF MONEY OR DESCRIPTION AND
NAME OF TRUST OR OTHER	DATE(S) OF	VALUE OF PROPERTY OR DEBTOR'S INTEREST
DEVICE	TRANSFER(S)	IN PROPERTY


		11. Closed financial accounts

		List all financial accounts and instruments held in the name of the debtor or for the benefit of the debtor which were closed, sold, or otherwise transferred within one year immediately preceding the commencement of this case. Include checking, savings, or other financial accounts, certificates of deposit, or other instruments; shares and share accounts held in banks, credit unions, pension funds, cooperatives, associations, brokerage houses and other financial institutions. (Married debtors filing under chapter 12 or chapter 13 must include information concerning accounts or instruments held by or for either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)


	TYPE OF ACCOUNT, LAST FOUR
	DIGITS OF ACCOUNT NUMBER,	AMOUNT AND DATE OF SALE
NAME AND ADDRESS OF INSTITUTION	AND AMOUNT OF FINAL BALANCE	OR CLOSING
Wells Fargo Bank	Savings account	September 29, 2008, $90,994.63


		12. Safe deposit boxes

None þ		List each safe deposit or other box or depository in which the debtor has or had securities, cash, or other valuables within one year immediately preceding the commencement of this case. (Married debtors filing under chapter 12 or chapter 13 must include boxes or depositories of either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)


		13. Setoffs

None þ		List all setoffs made by any creditor, including a bank, against a debt or deposit of the debtor within 90 days preceding the commencement of this case. (Married debtors filing under chapter 12 or chapter 13 must include information concerning either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)


NAME AND ADDRESS OF CREDITOR	DATE OF SETOFF	AMOUNT OF SETOFF


		14. Property held for another person

None þ		List all property owned by another person that the debtor holds or controls.


	DESCRIPTION AND VALUE OF
NAME AND ADDRESS OF OWNER	PROPERTY	LOCATION OF PROPERTY


		15. Prior address of debtor

		If the debtor has moved within three years immediately preceding the commencement of this case, list all premises which the debtor occupied during that period and vacated prior to the commencement of this case. If a joint petition is filed, report also any separate address of either spouse.


ADDRESS:	NAME USED	DATES OF OCCUPANCY
6611 Dumbarton Circle Fremont, CA 94555	Vermillion Inc	Aug, 2000 — July 2008



Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


		16. Spouses and Former Spouses

None þ		If the debtor resides or resided in a community property state, commonwealth, or territory (including Alaska, Arizona, California, Idaho, Louisiana, Nevada, New Mexico, Puerto Rico, Texas, Washington, or Wisconsin) within eight years immediately preceding the commencement of the case, identify the name of the debtor’s spouse and of any former spouse who resides or resided with the debtor in the community property state.


NAME


		17. Environmental Information.

		For the purpose of this question, the following definitions apply:

		“Environmental Law” means any federal, state, or local statute or regulation regulating pollution, contamination, releases of hazardous or toxic substances, wastes or material into the air, land, soil, surface water, groundwater, or other medium, including, but not limited to, statutes or regulations regulating the cleanup of these substances, wastes, or material.

		“Site” means any location, facility, or property as defined under any Environmental Law, whether or not presently or formerly owned or operated by the debtor, including, but not limited to, disposal sites. “Hazardous Material” means anything defined as a hazardous waste, hazardous substance, toxic substance, hazardous material, pollutant, or contaminant or similar term under an Environmental Law

None þ		a. List the name and address of every site for which the debtor has received notice in writing by a governmental unit that it may be liable or potentially liable under or in violation of an Environmental Law. Indicate the governmental unit, the date of the notice, and, if known, the Environmental Law:

NAME AND ADDRESS OF

DATE OF

ENVIRONMENTAL

SITE NAME AND ADDRESS

GOVERNMENTAL UNIT

NOTICE

LAW


None þ		b. List the name and address of every site for which the debtor provided notice to a governmental unit of a release of Hazardous Material. Indicate the governmental unit to which the notice was sent and the date of the notice.

NAME AND ADDRESS OF

DATE OF

ENVIRONMENTAL

SITE NAME AND ADDRESS

GOVERNMENTAL UNIT

NOTICE

LAW


None þ		c. List all judicial or administrative proceedings, including settlements or orders, under any Environmental Law with respect to which the debtor is or was a party. Indicate the name and address of the governmental unit that is or was a party to the proceeding, and the docket number.


NAME AND ADDRESS OF
GOVERNMENTAL UNIT	DOCKET NUMBER	STATUS OR DISPOSITION


		18 . Nature, location and name of business

		a. If the debtor is an individual, list the names, addresses, taxpayer identification numbers, nature of the businesses, and beginning and ending dates of all businesses in which the debtor was an officer, director, partner, or managing executive of a corporation, partner in a partnership, sole proprietor, or was self-employed in a trade, profession, or other activity either full- or part-time within six years immediately preceding the commencement of this case, or in which the debtor owned 5 percent or more of the voting or equity securities within six years immediately preceding the commencement of this case.

		If the debtor is a partnership, list the names, addresses, taxpayer identification numbers, nature of the businesses, and beginning and ending dates of all businesses in which the debtor was a partner or owned 5 percent or more of the voting or equity securities, within six years immediately preceding the commencement of this case.

		If the debtor is a corporation, list the names, addresses, taxpayer identification numbers, nature of the businesses, and beginning and ending dates of all businesses in which the debtor was a partner or owned 5 percent or more of the voting or equity securities within six years immediately preceding the commencement of this case.



Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


	LAST FOUR DIGITS OF
	SOCIAL-SECURITY OR
	OTHER INDIVIDUAL
	TAXPAYER-I.D. NO.			BEGINNING AND
NAME	(ITIN)/ COMPLETE EIN	ADDRESS	NATURE OF BUSINESS	ENDING DATES
Ciphergen Biosystems Inc Vermillion, Inc See attached file- Form 7, question 18-a	33-0595156	6611 Dumbarton Circle, Fremont, CA 94555 47350 Fremont Blvd., Fremont, CA 94538	Business is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients	Originally incorporated in California on December 9, 1993, filled chapter 11 on March 31, 2009


None		b. Identify any business listed in response to subdivision a., above, that is “single asset real estate” as defined in 11 U.S.C. § 101.


NAME				ADDRESS

The following questions are to be completed by every debtor that is a corporation or partnership and by any individual debtor who is or has been, within six years immediately preceding the commencement of this case, any of the following: an officer, director, managing executive, or owner of more than 5 percent of the voting or equity securities of a corporation; a partner, other than a limited partner, of a partnership, a sole proprietor or self-employed in a trade, profession, or other activity, either full- or part-time.

(An individual or joint debtor should complete this portion of the statement only if the debtor is or has been in business, as defined above, within six years immediately preceding the commencement of this case. A debtor who has not been in business within those six years should go directly to the signature page.)


		19. Books, records and financial statements

		a. List all bookkeepers and accountants who within two years immediately preceding the filing of this bankruptcy case kept or supervised the keeping of books of account and records of the debtor.


NAME AND ADDRESS		DATES SERVICES RENDERED
The company itself


		b. List all firms or individuals who within the two years immediately preceding the filing of this bankruptcy case have audited the books of account and records, or prepared a financial statement of the debtor.


NAME	ADDRESS	DATES SERVICES RENDERED
PricewaterhouseCoopers LLP	Ten Almaden Blvd, Suite 1600, San Jose, CA 95113	Year end and quarter end


		c. List all firms or individuals who at the time of the commencement of this case were in possession of the books of account and records of the debtor. If any of the books of account and records are not available, explain.


NAME		ADDRESS
The company (debtor itself)		47350 Fremont Blvd. Fremont, CA 94538


None þ		d. List all financial institutions, creditors and other parties, including mercantile and trade agencies, to whom a financial statement was issued by the debtor within two years immediately preceding the commencement of this case.


NAME AND ADDRESS		DATE ISSUED



Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


		20. Inventories

None þ		a. List the dates of the last two inventories taken of your property, the name of the person who supervised the taking of each inventory, and the dollar amount and basis of each inventory.


		DOLLAR AMOUNT OF INVENTORY
DATE OF INVENTORY	INVENTORY SUPERVISOR	(Specify cost, market or other basis)


None þ		b. List the name and address of the person having possession of the records of each of the two inventories reported in a., above.


		NAME AND ADDRESSES OF CUSTODIAN OF INVENTORY
DATE OF INVENTORY		RECORDS


		21 . Current Partners, Officers, Directors and Shareholders

None þ		a. If the debtor is a partnership, list the nature and percentage of partnership interest of each member of the partnership.


NAME AND ADDRESS	NATURE OF INTEREST	PERCENTAGE OF INTEREST


		b. If the debtor is a corporation, list all officers and directors of the corporation, and each stockholder who directly or indirectly owns, controls, or holds 5 percent or more of the voting or equity securities of the corporation.


		NATURE AND PERCENTAGE
NAME AND ADDRESS	TITLE	OF STOCK OWNERSHIP
PAGE, Gail	Executive Chairman of the Board of
47350 Fremont Blvd, Fremont, CA 94539	Directors

Burns, James	Director
47350 Fremont Blvd, Fremont, CA 94539

HAMILTON, John	Director
47350 Fremont Blvd, Fremont, CA 94539

Highbridge International LLC	Stockholder		7.29	%
9W 57^th Street, 27^th Floor, New York, NY 10019

Ironwood Investment Management, LLC	Stockholder		13.13	%
21 Custom House Street, Suite 240 Boston, MA 02110

OppenheirmerFunds, Inc	Stockholder		10.08	%
225 Liberty Street, New York, NY 10281

Phronesis Partners, L.P	Stockholder		10.38	%
180 E Broad Street # 1704, Columbus, OH 43215

Quest Diagnostics, Inc.	Stockholder		13.48	%
3 Giralda Farms, Madison, NJ 07940

Falcon Technology Partners L.P	Stockholder		6.88	%
600 Dorset Road, Devon, PA 19333


		22 . Former partners, officers, directors and shareholders

None þ		a. If the debtor is a partnership, list each member who withdrew from the partnership within one year immediately preceding the commencement of this case.


NAME	ADDRESS	DATE OF WITHDRAWAL



Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


		b. If the debtor is a corporation, list all officers, or directors whose relationship with the corporation terminated within one year immediately preceding the commencement of this case.


NAME AND ADDRESS	TITLE	DATE OF TERMINATION
CONWAY, Kenneth J.
REDACTED	Director	March 25, 2009

DALAL, Rajen
REDACTED	Director	March 30, 2009

RATHMANN, James L.
REDACTED	Executive Chairman	March 25, 2009

YOUNG, John A
REDACTED	Lead Outside Director	March 26, 2009

PAGE, Gail
REDACTED	President, CEO	March 27, 2009

FUNG, Eric
REDACTED	Chief Scientific Officer	March 19, 2009

SHORTER, Simon
REDACTD	VP- Business Development	March 27, 2009

ZHOU, Qun
REDACTED	Interim CFO	March 27, 2009


		23. Withdrawals from a partnership or distributions by a corporation

None		If the debtor is a partnership or corporation, list all withdrawals or distributions credited or given to an insider, including compensation in any form, bonuses, loans, stock redemptions, options exercised and any other perquisite during one year immediately preceding the commencement of this case.


NAME & ADDRESS		AMOUNT OF MONEY OR
OF RECIPIENT,	DATE AND PURPOSE	DESCRIPTION AND
RELATIONSHIP TO DEBTOR	OF WITHDRAWAL	VALUE OF PROPERTY
See attached file, Form 7, question 23


		24. Tax Consolidation Group.

None þ		If the debtor is a corporation, list the name and federal taxpayer identification number of the parent corporation of any consolidated group for tax purposes of which the debtor has been a member at any time within six years immediately preceding the commencement of the case.



NAME OF PARENT CORPORATION		TAXPAYER IDENTIFICATION NUMBER (EIN)


		25. Pension Funds.

None þ		If the debtor is not an individual, list the name and federal taxpayer identification number of any pension fund to which the debtor, as an employer, has been responsible for contributing at any time within six years immediately preceding the commencement of the case.



NAME OF PENSION FUND		TAXPAYER IDENTIFICATION NUMBER (EIN)



Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037		Best Case Bankruptcy

Form 7, question 3-b
CHECK HISTORY REPORT JANUARY 1, 2009 — MARCH 31, 2009

VENDOR NAME

ADDRESS

Payment Date

Amount Paid

Amount Still Owing

Payment Method

ABFO

P.O. BOX 2103, Fremont CA 94536-0103

1/29/2009

250

Check

ALAMEDA COUNTY

P.O. Box N,Alameda CA 94501-0108

1/29/2009

775

Check

ALLIED WASTE SERVICES #9

P.O. BOX 78829, Phoenix AZ 85062-8829

1/8/2009

1,991.14

Check

ALLIED WASTE SERVICES #9

P.O. BOX 78829, Phoenix AZ 85062-8829

2/13/2009

1,991.14

Check

ALLIED WASTE SERVICES #9

P.O. BOX 78829, Phoenix AZ 85062-8829

3/13/2009

1,991.14

Check

AMERICAN EXPRESS

2975 W. Corporate Lakes Blvd., Weston FL 33331-3626

1/8/2009

2,290.97

Check

AMERICAN EXPRESS

2976 W. Corporate Lakes Blvd., Weston FL 33331-3626

2/13/2009

7,888.01

Check

AMERICAN EXPRESS

2977 W. Corporate Lakes Blvd., Weston FL 33331-3626

3/13/2009

878.31

Check

AMERICAN EXPRESS CO.

P.O. Box 360001, Ft. Lauderdale FL 33336-0001

1/29/2009

4,969.00

Check

AMERICAN EXPRESS CO.

P.O. Box 360001, Ft. Lauderdale FL 33336-0001

2/13/2009

309.4

Check

ANTHEM BLUE CROSS

P.O. BOX 54630, Los Angeles CA 90054-0630

1/29/2009

11,427.00

Check

ANTHEM BLUE CROSS

P.O. BOX 54630, Los Angeles CA 90054-0630

2/27/2009

8,778.00

Check

ANTHEM BLUE CROSS

P.O. BOX 54630, Los Angeles CA 90054-0630

3/13/2009

6,824.00

Check

APPLIED CLINICAL INTELLI

225 City Avenue, Suite 15, Bala Cynwyd PA 19004

2/27/2009

5,000.00

Check

AT & T MOBILITY

P.O. BOX 9004, Carol Stream IL 60197-9004

1/29/2009

1,739.75

Check

AT & T MOBILITY

P.O. BOX 9004, Carol Stream IL 60197-9004

2/27/2009

2,119.43

Check

AT & T MOBILITY

P.O. BOX 9004, Carol Stream IL 60197-9004

3/13/2009

1,538.37

Check

AT&T

P.O. BOX 5019, Carol Stream IL 60197-5019

1/8/2009

505.75

Check

AT&T

PAYMENT CENTER, Sacramento CA 95887-0001

1/8/2009

100.41

Check

AT&T

PAYMENT CENTER, Sacramento CA 95887-0001

1/29/2009

1,185.28

Check

AT&T

P.O. BOX 5019, Carol Stream IL 60197-5019

2/13/2009

874.65

Check

AT&T

PAYMENT CENTER, Sacramento CA 95887-0001

2/13/2009

842.88

Check

AT&T

P.O. BOX 5019, Carol Stream IL 60197-5019

2/27/2009

404.16

Check

BARKHURST, DAVID

REDACTED

1/12/2009

1,136.74

Check

BARKHURST, DAVID

REDACTED

1/29/2009

640

Check

BARKHURST, DAVID

REDACTED

2/13/2009

120

Check

BAY ALARM COMPANY

P.O. BOX 7137,San Francisco CA 94120-7137

1/29/2009

339

Check

BOWNE OF LOS ANGELES, IN

P.O. Box 79358, City of Industry CA 91716-9358

2/13/2009

4,191.00

Check

BOWNE OF LOS ANGELES, IN

P.O. Box 79358, City of Industry CA 91716-9358

2/27/2009

1,405.00

Check

BOWNE OF LOS ANGELES, IN

P.O. Box 79358, City of Industry CA 91716-9358

3/13/2009

413

Check

CALIFORNIA BOARD OF

P.O. Box 942879, Sacramento CA 94279-6009

1/21/2009

3,098.00

Wire Transfer

CAREY INTERNATIONAL INC.

P.O. Box 631414, Baltimore MD 21263-1414

1/29/2009

670.77

Check

CARRUTHERS, SUSAN D.

REDACTED

1/15/2009

72.62

Direct Deposit

CARRUTHERS, SUSAN D.

REDACTED

2/27/2009

107.64

Direct Deposit

CARRUTHERS, SUSAN D.

REDACTED

3/13/2009

85.04

Direct Deposit

CHAVEZ, JESUS N.

REDACTED

1/21/2009

1,645.00

Check

CHAVEZ, JESUS N.

REDACTED

1/29/2009

87.5

Check

CHAVEZ, JESUS N.

REDACTED

2/27/2009

61.25

Check

CINTAS DOCUMENT MANAGEME

P.O. Box 633842, Cincinnati OH 45263-3842

1/29/2009

140.35

Check

CINTAS DOCUMENT MANAGEME

P.O. Box 633842, Cincinnati OH 45263-3842

2/27/2009

Check

CIT TECHNOLOGY FIN SERV,

P.O. Box 100706, Pasadena CA 91189-0706

1/8/2009

336.82

Check

CIT TECHNOLOGY FIN SERV,

P.O. Box 100706, Pasadena CA 91189-0706

1/29/2009

336.82

Check

CIT TECHNOLOGY FIN SERV,

P.O. Box 100706, Pasadena CA 91189-0706

3/13/2009

336.82

Check

CONEXIS

P.O. Box 5547, Orange CA 92863-5547

1/15/2009

Check

CONEXIS

P.O. Box 5547, Orange CA 92863-5547

2/13/2009

Check

VENDOR NAME

ADDRESS

Payment Date

Amount Paid

Amount Still Owing

Payment Method

CONEXIS

P.O. Box 5547, Orange CA 92863-5547

3/13/2009

Check

CONTROL SOLUTIONS

400 Amherst St. Suite 201, Nashua NH 03063

2/13/2009

13,760.00

Check

CREECH, WILLIAM B.

2237 Mount Vernon Lane, Auburn AL 36830

1/29/2009

6,490.41

Check

CREECH, WILLIAM B.

2237 Mount Vernon Lane, Auburn AL 36830

2/13/2009

3,687.50

Check

CREECH, WILLIAM B.

2237 Mount Vernon Lane, Auburn AL 36830

3/13/2009

4,125.00

Check

CRUTCHER, GILLIAN

REDACTED

3/13/2009

82.52

Direct Deposit

CRUTCHER, GILLIAN

REDACTED

3/31/2009

125.05

Direct Deposit

CT CORPORATION

P.O. Box 4349, Carol Stream IL 60197-4349

1/8/2009

618

Check

DELAWARE SECRETARY OF ST

Corporation Trust Center,1209 Orange Street, Wilmington DE 19801

2/26/2009

21,093.64

Check

DELOITTE TAX LLP

P.O. BOX 2079,Carol Stream IL 60132-2079

1/8/2009

20,000.00

Check

DELOITTE TAX LLP

P.O. BOX 2079,Carol Stream IL 60132-2079

2/13/2009

25,000.00

Check

DELOITTE TAX LLP

P.O. BOX 2079,Carol Stream IL 60132-2079

2/27/2009

5,000.00

Check

DELOITTE TAX LLP

P.O. BOX 2079,Carol Stream IL 60132-2079

3/13/2009

5,000.00

Check

DELOITTE TOUCHE TOHMATSU

8/F Office Tower W2,1 East Chang An Avenue, Beijing 100738, PRC

1/6/2009

4,204.00

Wire Transfer

E*TRADE FINANCIAL

P.O. Box 3512, Arlington VA 22203

2/27/2009

5,098.23

Check

EDWARDS & ANGELL LLP

P.O. BOX 40956, Hartford CT 06150-0956

1/8/2009

59,863.20

Check

ENDSIGHT

1440 Fourth Street Suite B, Berkeley CA 94710

1/29/2009

5,100.00

Check

ENDSIGHT

1440 Fourth Street Suite B, Berkeley CA 94710

2/13/2009

5,175.00

Check

ENDSIGHT

1440 Fourth Street Suite B, Berkeley CA 94710

2/27/2009

100

Check

EXEC-U-CARE

P.O. BOX 533204, Atlanta GA 30353-3204

1/15/2009

1,110.56

Check

EXEC-U-CARE

P.O. BOX 533204, Atlanta GA 30353-3204

1/29/2009

919.67

Check

FACILITIES MAINTENANCE S

266 Gifford Avenue, San Jose CA 95110

1/29/2009

987

Check

FACILITIES MAINTENANCE S

266 Gifford Avenue, San Jose CA 95110

2/27/2009

459.77

Check

FEDEX ERS

P.O. Box 371741, Pittsburgh PA 15250-7741

1/8/2009

349.74

Check

FEDEX ERS

P.O. Box 371741, Pittsburgh PA 15250-7741

1/29/2009

692.08

Check

FEDEX ERS

P.O. Box 371741, Pittsburgh PA 15250-7741

2/27/2009

213.33

Check

FEDEX ERS

P.O. Box 371741, Pittsburgh PA 15250-7741

3/13/2009

222.02

Check

FIDELITY INVESTMENTS

P.O. Box 73307, Chicago IL 60673-7307

2/27/2009

637

Check

FIDELITY MANAGEMENT TRUS

100 Crosby Parkway,Mailzone KC1F-E, Covington KY 41015-4323

1/29/2009

1,793.23

Check

FPRS DEPOSITORY ACCOUNT

P.O. Box 73307, Chicago IL 60673-7307

1/8/2009

2,277.50

Auto-Debit

FPRS DEPOSITORY ACCOUNT

P.O. Box 73307, Chicago IL 60673-7307

1/20/2009

12,891.62

Auto-Debit

FPRS DEPOSITORY ACCOUNT

P.O. Box 73307, Chicago IL 60673-7307

2/4/2009

21,913.98

Auto-Debit

FPRS DEPOSITORY ACCOUNT

P.O. Box 73307, Chicago IL 60673-7307

2/19/2009

13,000.57

Auto-Debit

FUNG, ERIC

REDACTED

1/15/2009

346.29

Direct Deposit

FUNG, ERIC

REDACTED

2/27/2009

2,822.69

Direct Deposit

GADOL, NANCY

301 Molton Ave. San Carlos CA 94070

2/13/2009

3,375.00

Check

GLOBAL CROSSING CONFEREN

Dept. 518, Denver CO 80291-0518

1/29/2009

583.71

Check

GLOBAL CROSSING CONFEREN

Dept. 518, Denver CO 80291-0518

2/13/2009

107.65

Check

GLOBAL CROSSING CONFEREN

Dept. 518, Denver CO 80291-0518

3/13/2009

103.64

Check

GOUFFRANT, CECILE

280 41st Street, Oakland CA 94611

1/29/2009

2,100.00

Check

GOUFFRANT, CECILE

280 41st Street, Oakland CA 94611

2/27/2009

1,050.00

Check

HAMILTON, JOHN F.

REDACTED

3/25/2009

5,000.00

Check

HARPER, MARIBETH R.

REDACTED

1/29/2009

236.25

Check

HARRIS, PAUL C.

3022 184th PI. SE, Bothell WA 98012

2/13/2009

1,125.00

Check

HYMAN, PHELPS & MCNAMARA

700 13th Street, Suite 1200, Washington DC 20005

1/29/2009

8,100.00

Check

HYMAN, PHELPS & MCNAMARA

700 13th Street, Suite 1200, Washington DC 20005

2/27/2009

840

Check

IMAGINE CENTER L.P.

911 Ranch Rd 620 North Suite 100, Lakeway TX 78734

1/8/2009

240

Check

IRON MOUNTAIN

P.O. BOX 601002, Los Angeles CA 90060-1002

1/29/2009

665.02

Check

IRON MOUNTAIN

P.O. BOX 601002, Los Angeles CA 90060-1002

2/13/2009

370.66

Check

VENDOR NAME

ADDRESS

Payment Date

Amount Paid

Amount Still Owing

Payment Method

IRON MOUNTAIN

P.O. BOX 601002, Los Angeles CA 90060-1002

3/13/2009

290.72

Check

JOHNS HOPKINS UNIVERSITY

JHU CENTRAL LOCKBOX, Bank of America, 12529 Collections Center Drive, Chicago IL 60693

1/29/2009

42,915.00

Check

JOHNS HOPKINS UNIVERSITY

JHU CENTRAL LOCKBOX, Bank of America, 12529 Collections Center Drive, Chicago IL 60693

1/30/2009

50,000.00

Check

JOHNS HOPKINS UNIVERSITY

JHU CENTRAL LOCKBOX, Bank of America, 12529 Collections Center Drive, Chicago IL 60693

2/13/2009

40,000.00

Check

JONES, JAMES V.

REDACTED

2/13/2009

4,071.13

Check

LAND ROVER CAPITAL GROUP

Department #193901, P.O. BOX 55000, Detroit MI 48255-1939

1/8/2009

1,363.77

Check

LAND ROVER CAPITAL GROUP

Department #193901, P.O. BOX 55000, Detroit MI 48255-1939

1/29/2009

1,363.77

Check

LAND ROVER CAPITAL GROUP

Department #193901, P.O. BOX 55000, Detroit MI 48255-1939

2/27/2009

1,363.77

Check

LANDESS, TINA M.

REDACTED

1/21/2009

1,600.00

Check

LANDESS, TINA M.

REDACTED

1/21/2009

1,600.00

Check

MESSAGELABS, INC.

512 Seventh Avenue 6th Floor, New York NY 10018

1/29/2009

337.5

Check

MOE, RHONDA

1022 Ocean Ln,Imperial Beach CA 91932

1/29/2009

1,235.00

Check

MOE, RHONDA

1023 Ocean Ln,Imperial Beach CA 91932

2/13/2009

390

Check

MONTGOMERY PROFESSIONAL

File #031052, P.O. BOX 60000, San Francisco CA 94160

1/8/2009

7,830.00

Check

MONTGOMERY PROFESSIONAL

File #031052, P.O. BOX 60000, San Francisco CA 94160

1/29/2009

12,060.00

Check

MONTGOMERY PROFESSIONAL

File #031052, P.O. BOX 60000, San Francisco CA 94160

2/13/2009

13,140.00

Check

MONTGOMERY PROFESSIONAL

File #031052, P.O. BOX 60000, San Francisco CA 94160

2/27/2009

5,760.00

Check

MONTGOMERY PROFESSIONAL

File #031052, P.O. BOX 60000, San Francisco CA 94160

3/17/2009

8,640.00

Check

NAIR & CO

Whitefriars, Lewins Mead, Bristol BS1 2NT, UK

2/10/2009

17,000.00

Wire Transfer

NAIR & CO

Whitefriars, Lewins Mead, Bristol BS1 2NT, UK

2/27/2009

20,000.00

Wire Transfer

NAIR & CO

Whitefriars, Lewins Mead, Bristol BS1 2NT, UK

3/9/2009

7,000.00

Wire Transfer

NATIONAL ONCOLOGY ALLIAN

750 Lindaro Street, Suite 350, San Rafael CA 94901

1/8/2009

25,000.00

Check

NELDA WELLS SPEARS

TRAVIS CNTY TAX ASSESSOR-COL, 5501 AIRPORT BLVD, P.O. BOX 149326, Austin TX 78714-9326

1/29/2009

65.3

Check

OFFICE DEPOT

P.O. Box 70001, Los Angeles CA90074-0001

1/29/2009

195.36

Check

OFFICE DEPOT

P.O. Box 70001, Los Angeles CA90074-0001

2/13/2009

39.11

Check

P G & E

Box 997300, Sacramento CA 95899-7300

1/29/2009

1,217.77

Check

P G & E

Box 997300, Sacramento CA 95899-7300

2/13/2009

1,341.67

Check

PAGE, GAIL

REDACTED

1/15/2009

707.62

Direct Deposit

PAGE, GAIL

REDACTED

2/27/2009

812.72

Direct Deposit

PALLIS, KATHERINE C.

87 Encantado Loop, Santa Fe NM 87508

1/29/2009

5,524.20

Check

PAUL, HASTINGS, JANOFSKY

55 Second Street, 24th Floor, San Francisco CA 94105-3441

1/8/2009

48,000.00

Check

PAUL, HASTINGS, JANOFSKY

55 Second Street, 24th Floor, San Francisco CA 94105-3441

2/6/2009

50,663.23

Check

PAUL, HASTINGS, JANOFSKY

55 Second Street, 24th Floor, San Francisco CA 94105-3441

2/13/2009

11,501.25

Check

PAUL, HASTINGS, JANOFSKY

55 Second Street, 24th Floor, San Francisco CA 94105-3441

2/27/2009

15,000.00

Check

PAUL, HASTINGS, JANOFSKY

55 Second Street, 24th Floor, San Francisco CA 94105-3441

3/13/2009

5,000.00

Check

PAUL, HASTINGS, JANOFSKY

55 Second Street, 24th Floor, San Francisco CA 94105-3441

3/25/2009

170,000.00

Wire Transfer

PITNEY BOWES GLOBAL

P.O. Box 856460, Louisville KY 40285-6460

3/13/2009

931.96

Check

PR NEWSWIRE

G.P.O. BOX 5897, New York NY 10087-5897

1/29/2009

1,060.50

Check

PRAXAIR DISTRIBUTION, IN

Dept LA 21511, Pasadena CA 91185-1511

1/29/2009

52.19

Check

PRAXAIR DISTRIBUTION, IN

Dept LA 21511, Pasadena CA 91185-1511

3/13/2009

26.46

Check

PRECISIONMED INC.

132 N. Acacia Avenue, Solana Beach CA 92075

1/8/2009

4,341.00

Check

PRECISIONMED INC.

132 N. Acacia Avenue, Solana Beach CA 92075

2/27/2009

5,000.00

Check

PRICEWATERHOUSECOOPERS L

P.O. Box 31001-0068, Pasadena CA 91110-0068

2/13/2009

7,675.00

Check

PRICEWATERHOUSECOOPERS L

P.O. Box 31001-0068, Pasadena CA 91110-0068

3/13/2009

5,000.00

Check

PRINCIPAL LIFE GROUP

P.O. BOX 14513, Des Moines IA 50306-3513

1/15/2009

1,004.26

Check

PRINCIPAL LIFE GROUP

P.O. BOX 14513, Des Moines IA 50306-3513

2/27/2009

1,071.90

Check

PRINCIPAL LIFE INSURANCE

P.O. BOX 10372, Des Moines IA 50306-3513

1/15/2009

1,203.70

Check

PRINCIPAL LIFE INSURANCE

P.O. BOX 10372, Des Moines IA 50306-3513

2/13/2009

1,203.70

Check

PRINCIPAL LIFE INSURANCE

P.O. BOX 10372, Des Moines IA 50306-3513

2/13/2009

812.65

Check

VENDOR NAME

ADDRESS

Payment Date

Amount Paid

Amount Still Owing

Payment Method

PRINCIPAL LIFE INSURANCE

P.O. BOX 10372, Des Moines IA 50306-3513

2/27/2009

608.66

Check

PROCESSWORKS

250 N. Patrick Blvd Suite 125, Brookfield WI 53045

1/29/2009

1,479.95

Check

PROCESSWORKS INC.

P.O.Box 712748, Cincinnati OH 45271-2748

1/15/2009

604

Check

PROCESSWORKS INC.

P.O.Box 712748, Cincinnati OH 45271-2748

2/13/2009

Check

PROCESSWORKS INC.

P.O.Box 712748, Cincinnati OH 45271-2748

3/13/2009

Check

PROLOGIS LIMITED PARTNER

4545 Airport Way, Denver CO 80239

1/29/2009

9,076.06

Check

PROLOGIS LIMITED PARTNER

4545 Airport Way, Denver CO 80239

2/27/2009

9,076.06

Check

PROLOGIS LIMITED PARTNER

4545 Airport Way, Denver CO 80239

3/13/2009

9,076.06

Check

PUBLIC STORAGE

24211-FREMONT/ALBRAE, 42101 Albrae Street, Fremont CA 94538-3123

1/29/2009

257

Check

PUBLIC STORAGE, INC.

1096 FAIR OAKS AVENUE, SUNNYVALE CA 94089

2/27/2009

255

Check

PUBLIC STORAGE, INC.

1096 FAIR OAKS AVENUE, SUNNYVALE CA 94089

3/13/2009

255

Check

PURCHASE POWER

P.O. BOX 856042, Louisville KY 40285-6042

1/8/2009

206.99

Check

QUEST DIAGNOSTICS, INC.

P.O. Box 5001, Collegeville PA 19426

1/5/2009

34,931.51

Wire Transfer

QUEST DIAGNOSTICS, INC.

P.O. Box 5001, Collegeville PA 19426

2/11/2009

31,849.31

Wire Transfer

QUINN EMANUEL URQUHART

865 South Figueroa Street 10th Floor, Los Angeles CA 90017

1/8/2009

18,060.89

Check

QUINN EMANUEL URQUHART

865 South Figueroa Street 10th Floor, Los Angeles CA 90017

2/27/2009

1,079.36

Check

SCHULMAN ASSOCIATES

4290 Glendale-Milford Rd. Cincinnati OH 45242

1/29/2009

1,475.00

Check

SHORTER, SIMON

REDACTED

1/15/2009

227.28

Direct Deposit

SHORTER, SIMON

REDACTED

2/27/2009

343.97

Direct Deposit

SHORTER, SIMON

REDACTED

3/13/2009

155.11

Direct Deposit

SHORTER, SIMON

REDACTED

3/31/2009

44.99

Direct Deposit

SIGMA-ALDRICH, INC.

P.O. BOX 535182, Atlanta GA 30353-5182

3/13/2009

108.13

Check

STANFORD UNIVERSITY

Department #44439, P.O. BOX 44000, San Francisco CA 94144-4439

1/29/2009

1,216.00

Check

STERICYCLE INC.

P.O. Box 9001589, Louisville KY 40290-1589

1/29/2009

1,001.22

Check

STERICYCLE INC.

P.O. Box 9001589, Louisville KY 40290-1589

2/13/2009

500.61

Check

STERICYCLE INC.

P.O. Box 9001589, Louisville KY 40290-1589

3/13/2009

500.61

Check

TESTORFF, CHARLOTTE

1841 Alburn Place, El Dorado Hills CA 95762

1/21/2009

3,000.00

Check

TESTORFF, CHARLOTTE

1841 Alburn Place, El Dorado Hills CA 95762

1/29/2009

3,000.00

Check

TESTORFF, CHARLOTTE

1841 Alburn Place, El Dorado Hills CA 95762

3/25/2009

1,500.00

Check

THOMSON FINANCIAL LLC

195 Broadway 7th Floor, New York NY 10007

2/13/2009

3,551.00

Check

TOWNSEND & TOWNSEND ET A

TWO EMBARCADERO CENTER 8TH FLOOR, SAN FRANCISCO CA 94111-3834

1/8/2009

3,101.74

Check

US BANK

60 Livingston Avenue, Saint Paul MN 55107

1/5/2009

15,762.05

Wire Transfer

VISION SERVICE PLAN — (C

P.O. BOX 45210, San Francisco CA 94145-5210

1/15/2009

104.85

Check

VISION SERVICE PLAN — (C

P.O. BOX 45210, San Francisco CA 94145-5210

1/29/2009

87.48

Check

VISION SERVICE PLAN — (C

P.O. BOX 45210, San Francisco CA 94145-5210

2/27/2009

87.48

Check

Vo, Kristy

REDACTED

1/29/2009

2,640.00

Check

Vo, Kristy

REDACTED

2/27/2009

1,320.00

Check

VWR INTERNATIONAL INC.

P.O. BOX 31001-1257, Pasadena CA 91110-1257

1/29/2009

403.58

Check

Wells Fargo of CA Ins. S

Dept. 33457 PO Box 39000, San Francisco CA 94139

3/13/2009

6,123.25

Check

WELLS FARGO SHAREOWNER S

P.O. Box 64875, St. Paul MN 55164-0875

2/13/2009

1,407.00

Check

WOMBLE CARLYLE SANDRIDGE

222 Delaware Avenue, Suite 1501 Wilmington, DE 19801

3/27/2009

30,000.00

Wire Transfer

YIP, CHRISTINE I.

REDACTED

3/13/2009

1,850.28

Direct Deposit

YIP, CHRISTINE I.

REDACTED

3/31/2009

28.98

Direct Deposit

ZHANG, DR. ZHEN

14104 Big Branch Drive, Dayton MD 21036

1/29/2009

332.96

Check

Report Total

1,148,345.32

Form 7, question 3-c

Name

Address

Relationship

Date of Payment

Total Amount Paid

Amount Still Owing

Payment Method

John Hamilton

REDACTED

Director

$10,000 on 11/21/08, $5,000 on 3/25/09

15,000.00

Check

Gail Page

REDACTED

Director/President & CEO

3/15/08, 3/31/08, 4/15/08, 4/30/08, 5/15/08, 5/31/08, 6/15/08, 6/30/08, 7/15/08, 7/31/08, 8/15/08, 8/31/08, 9/15/08, 9/30/08, 10/15/08, 10/31/08, 11/15/08, 11/30/08, 12/15/08, 12/31/08, 1/15/09, 1/31/09, 2/15/09, 2/28/09, 3/15/09, 3/27/09

471,568.88

Semi-monthly Payroll Direct Deposit

Eric Fung

REDACTED

VP & Chief Science Officer

250,520.22

Semi-monthly Payroll Direct Deposit

Simon Shorter

REDACTED

VP of Business Development

225,515.00

Semi-monthly Payroll Direct Deposit

Qun Zhou

REDACTED

Interim CFO & Corporate Controller

171,684.40

Semi-monthly Payroll Direct Deposit

Form 7, question 4-a

Parties of Litigation involving Vermillion

Case

Plaintiff

Defendant

Nature of Proceeding

Case #

Court

Plaintiff Contact

Address

Tel

Fax

MAS Litigation

Molecular Analytical Systems

Vermillion Bio-Rad

MAS alleges that Vermillion is in breach of its license agreement with MAS relating to SELDI technology

H032845

Court of Appeal of the State of California, Sixth Appellate District

Steve Ellenberg
Law Offices of Steven A. Ellenberg

Defendant Contact for MAS case
Melissa Baily
Quinn Emanuel Urquhart Oliver & Hedges, LLP

125 South Market St. Suite 1001
San Jose, CA 95113

50 California Street, 22nd Floor
San Francisco, CA 94111

408-998-8500 ext 202

(415) 875-6336

408-998-8503

(415) 875-6700

OPCO Litigation

Vermillion Inc

Oppenheimer & Co

Vermillion charges OPCO for mismanagement of Vermillion funds in OPCO account

09-00486

FINRA Dispute Resolution

Scott J. Link
Richard L. Stone
Ackerman, Link & Sartory, P.A.

Defendant Contact for OPCO case
David Bartholomew
Palmer, Lombardi & Donohue, LLP

222 Lakeview Avenue
Suite 1250 — Esperante
West Palm Beach, FL 33401

888 West 6th Street
12th Floor
Los Angeles, CA 90017

561-838-4100

(213) 688-0430

561-838-5305

Form 7, question 18-b

Foreign Subsidiaries


	Vermillion
Name of Entity	Ownership			Description
Ciphergen Biosystems GmbH ( Germany )		100	%	Entity was set up as the sales organization for ProteinChip systems when the company was still Ciphergen Biosystems. Entity had no operation activities since late 2006 after the company sold the Protein Chip tool business to Bio-Rad. Entity is in the final stage of liquidation at the time of filing.

Ciphergen Biosystems S.r.l ( Italy )		100	%	Same as CB GmbH

Ciphergen Biosystems EURL ( France)		100	%	Same as CB GmbH

Ciphergen (Beijing) Biosystems Co., Ltd. ( China )		100	%	Same as CB GmbH

Ciphergen Biosystems Ltd. (UK)		100	%	Already Liquidated

Ciphergen Biosystems A/S ( Denmark )		100	%	Already Liquidated

Ciphergen Biosystems AG ( Switzerland )		100	%	Already Liquidated

Ciphergen Biosystems KK ( Japan )		100	%	Entity was set up as the sales organization for ProteinChip systems when the company was still Ciphergen Biosystems. Entity had no operation activities since late 2006 after the company sold the Protein Chip tool business to Bio-Rad.

Ciphergen Biosystems International Inc.		100	%	Germany, France, Italy subsidiaries operates under CBII

Ciphergen Technologies Inc		100	%	Inactive US company

Illumesys Pacific Inc		100	%	Inactive US company

Form 7, question 23

Name

Address

Relationship

Date

Purpose

Stock Options

Grant Price

James Burns

REDACTED

Director

06/11/08

Annual Grant

18,000

$2.04

10/28/08

Grant in lieu of Cash Payment

12,500

$0.75

Kenneth Conway

REDACTED

Director

06/11/08

Annual Grant

20,500

$2.04

10/28/08

Grant in lieu of Cash Payment

12,500

$0.75

Rajen Dalal

REDACTED

Director

06/11/08

Annual Grant

20,500

$2.04

10/28/08

Grant in lieu of Cash Payment

12,500

$0.75

John Hamilton

REDACTED

Director

06/11/08

New member Grant

30,000

$2.04

James Rathmann

REDACTED

Chairman of the Board

06/11/08

Annual Grant

28,000

$2.04

10/28/08

Grant in lieu of Cash Payment

12,500

$0.75

John Young

REDACTED

Director

06/11/08

Annual Grant

18,000

$2.04

10/28/08

Grant in lieu of Cash Payment

12,500

$0.75

Gail Page

REDACTED

Director/President & CEO

07/18/08

Annual Grant

125,000

$2.30

Eric Fung

REDACTED

VP & Chief Science Officer

07/18/08

Annual Grant

40,000

$2.30

Simon Shorter

REDACTED

VP of Business Development

07/18/08

Annual Grant

20,000

$2.30

Qun Zhou

REDACTED

Interim CFO & Corporate Controller

07/18/08

Annual Grant

10,000

$2.30

B6 Summary (Form 6 — Summary) (12/07)

United States Bankruptcy Court
District of Delaware


In re	Vermillion, Inc.		Case No.	09-11091

		Debtor(s)	Chapter	11

SUMMARY OF SCHEDULES

Indicate as to each schedule whether that schedule is attached and state the number of pages in each. Report the totals from Schedules A, B, D, E, F, I, and J in the boxes provided. Add the amounts from Schedules A and B to determine the total amount of the debtor’s assets. Add the amounts of all claims from Schedules D, E, and F to determine the total amount of the debtor’s liabilities. Individual debtors also must complete the “Statistical Summary of Certain Liabilities and Related Data” if they file a case under chapter 7,11, or 13.

ATTACHED

NO. OF

NAME OF SCHEDULE

(YES/NO)

SHEETS

ASSETS

LIABILITIES

OTHER

A — Real Property

Yes

0.00

B — Personal Property

Yes

1,229,353.95

C — Property Claimed as Exempt

D — Creditors Holding Secured Claims

Yes

10,000,000.00

E — Creditors Holding Unsecured Priority Claims (Total of Claims on Schedule E)

Yes

0.00

F — Creditors Holding Unsecured Nonpriority Claims

Yes

21,749,642.25

G — Executory Contracts and Unexpired Leases

Yes

H — Codebtors

Yes

I — Current Income of Individual Debtor(s)

N/A

J — Current Expenditures of Individual Debtor(s)

N/A

TOTAL

1,229,353.95

31,749,642.35

United States Bankruptcy Court
District of Delaware


In re	Vermillion, Inc.		Case No.	09-11091

		Debtor(s)	Chapter	11

STATISTICAL SUMMARY OF CERTAIN LIABILITIES AND RELATED DATA (28 U.S.C. § 159)

If you are an individual debtor whose debts are primarily consumer debts, as defined in § 101(8) of the Bankruptcy Code (11 U.S.C. § 101(8)), filing a case under chapter 7, 11 or 13, you must report all information requested below.

þ Check this box if you are an individual debtor whose debts are NOT primarily consumer debts. You are not required to report any information here.

B6A (Official Form 6A) (12/07)


In re	Vermillion, Inc.		Case No.	09-11091

		Debtor(s)

SCHEDULE A — REAL PROPERTY

Except as directed below, list all real property in which the debtor has any legal, equitable, or future interest, including all property owned as a co-tenant, community property, or in which the debtor has a life estate. Include any property in which the debtor holds rights and powers exercisable for the debtor’s own benefit. If the debtor is married, state whether the husband, wife, both, or the marital community own the property by placing an “H,” “W,” “J,” or “C” in the column labeled “Husband, Wife, Joint, or Community.” If the debtor holds no interest in real property, write “None” under “Description and Location of Property.”

Do not include interests in executory contracts and unexpired leases on this schedule. List them in Schedule G — Executory Contracts and Unexpired Leases.

If an entity claims to have a lien or hold a secured interest in any property, state the amount of the secured claim. See Schedule D. If no entity claims to hold a secured interest in the property, write “none” in the column labeled “Amount of Secured Claim.”

If the debtor is an individual or if a joint petition is filed, state the amount of any exemption claimed in the property only in Schedule C — Property Claimed as Exempt.

CURRENT VALUE

OF DEBTOR’S

HUSBAND,

INTEREST IN

WIFE,

PROPERTY, WITHOUT

DESCRIPTION AND

JOINT,

DEDUCTING ANY

AMOUNT OF

LOCATION OF

NATURE OF DEBTOR’S

SECURED CLAIM

SECURED

PROPERTY

INTEREST IN PROPERTY

COMMUNITY

OR EXEMPTION

CLAIM

-NONE-

Total:

0.00

(Report also on Summary of Schedules)



Sheet 1 of 1 total sheets in Schedule of Real Property

Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


B6B (Official Form 6B) (12/07)
In re: Vermillion, Inc.		Case No. 09-11091 (CSS)

SCHEDULE B — PERSONAL PROPERTY

Except as directed below, list all personal property of the debtor of whatever kind. If the debtor has no property in one or more of the categories, place an ‘X’ in the appropriate position in the column labeled ‘None’. If additional space is needed in any category, attach a separate sheet properly identified with the case name, case number, and the number of the category. If the debtor is married, state whether the husband, wife, both, or the marital community own the property by placing an ‘H,’ ‘W,’ ‘J,’ or ‘C’ in the column labeled ‘HWJC.’ If the debtor is an individual or a joint petition is filed, state the amount of any exemptions claimed only in Schedule C — Property Claimed as Exempt.

Do not list interests in executory contracts and unexpired leases on this schedule. List them in Schedule G — Executory Contracts and Unexpired Leases.

If the property is being held for the debtor by someone else, state that person’s name and address under ‘Description and Location of Property.’ If the property is being held for a minor child, simply state the child’s initials and the name and address of the child’s parent or guardian, such as ‘A.B., a minor child, by John Doe, guardian.’ Do not disclose the child’s name. See, 11 U.S.C. §112 and Fed. R. Bankr. P. 1007 (m).

CURRENT VALUE OF

DEBTOR’S INTEREST IN

PROPERTY, WITHOUT

DEDUCTING ANY SECURED

TYPE OF PROPERTY

NONE

DESCRIPTION AND LOCATION OF PROPERTY

HWJC

CLAIM OR EXEMPTION

1. Cash on hand.

2. Checking, savings or other financial accounts, certificates of deposit or shares in banks, savings and loan, thrift, building and loan, and homestead associations, or credit unions, brokerage houses, or cooperatives.

As of 3/31/09
Silicon Valley Bank
Oppenheimer - Money market
Oppenheimer - Investment

$
$

610,214.31
3,701.57
(Book value $1m)

3. Security deposits with public utilities, telephone companies, landlords, and others.

LC for Landlord - SVB

100,000

4. Household goods and furnishings, including audio, video, and computer equipment.

Subtotal (Total on this page)

713,915.88



Footnote:

(1)

Page 1 of 7


B6B (Official Form 6B) (12/07) — Cont.
In re: Vermillion, Inc.		Case No. 09-11091 (CSS)

SCHEDULE B — PERSONAL PROPERTY
(Continuation Sheet)


					CURRENT VALUE OF
					DEBTOR’S INTEREST IN
					PROPERTY, WITHOUT
					DEDUCTING ANY SECURED
TYPE OF PROPERTY	NONE	DESCRIPTION AND LOCATION OF PROPERTY	HWJC		CLAIM OR EXEMPTION
11. Interests in an education IRA as defined in 26 U.S.C. § 530(b)(1) or under a qualified State tuition plan as defined in 26 U.S.C. § 529(b)(1). Give particulars. (File separately the record(s) of any such interest(s). 11 U.S.C. § 521(c).)	X
12. Interests in IRA, ERISA, Keogh, or other pension or profit sharing plans. Give particulars.	X
13. Stock and interests in incorporated and unincorporated businesses. Itemize.		Ciphergen Biosystems International Inc. ( CBII) Ciphergen Technologies Inc Illumesys Pacific Inc			100% owned subsidiary of Vermillion, set up for international sales for tool business already sold in late 2006 100% owned subsidiary of Vermillion, inactive Same as above
		Ciphergen Biosystems GmbH ( Germany )			100% owned by CBII, in process of liquidation
		Ciphergen Biosystems S.r.l ( Italy )			Same as GmbH
		Ciphergen Biosystems EURL ( France)			Same as GmbH
		Ciphergen (Beijing) Biosystems Co., Ltd. ( China )			100% owned subsidiary of Vermillion, in process of liquidation
		Ciphergen Biosystems KK ( Japan )			100% owned subsidiary of Vermillion,
14. Interests in partnerships or joint ventures. Itemize.	X
15. Government and corporate bonds and other negotiable and nonnegotiable instruments.	X

		Subtotal (Total on this page)		$	0

Page 3 of 7


B6B (Official Form 6B) (12/07) — Cont.
In re: Vermillion, Inc.		Case No. 09-11091 (CSS)

SCHEDULE B — PERSONAL PROPERTY
(Continuation Sheet)

CURRENT VALUE OF

DEBTOR’S INTEREST IN

PROPERTY, WITHOUT

DEDUCTING ANY SECURED

TYPE OF PROPERTY

NONE

DESCRIPTION AND LOCATION OF PROPERTY

HWJC

CLAIM OR EXEMPTION

16. Accounts Receivable.

17. Alimony, maintenance, support, and property settlements to which the debtor is or may be entitled. Give particulars.

18. Other liquidated debts owed to debtor including tax refunds. Give particulars.

19. Equitable or future interests, life estates, and rights or powers exercisable for the benefit of the debtor other than those listed in Schedule A — Real Property.

20. Contingent and noncontingent interests in estate of a decedent, death benefit plan, life insurance policy, or trust.

21. Other contingent and unliquidated claims of every nature, including tax refunds, counterclaims of the debtor, and rights to setoff claims. Give estimated value of each.

Vermilion vs Oppenheimer & Co.
Vermillion charges OPCO for mismanagement of Vermillion funds in OPCO account

unknown

Subtotal (Total on this page)

Page 4 of 7


B6B (Official Form 6B) (12/07) — Cont.
In re: Vermillion, Inc.		Case No. 09-11091 (CSS)

SCHEDULE B — PERSONAL PROPERTY
(Continuation Sheet)


				CURRENT VALUE OF
				DEBTOR’S INTEREST IN
				PROPERTY, WITHOUT
				DEDUCTING ANY SECURED
TYPE OF PROPERTY	NONE	DESCRIPTION AND LOCATION OF PROPERTY	HWJC	CLAIM OR EXEMPTION
22. Patents, copyrights, and other intellectual property. Give particulars.		See Exhibit 1
23. Licenses, franchises, and other general intangibles. Give particulars.		See Exhibit 2
24. Customer lists or other compilations containing personally identifiable information (as defined in 11 U.S.C. § 101 (41A)) provided to the debtor by individuals in connection with obtaining a product or service from the debtor primarily for personal, family, or household purposes.	X
25. Automobiles, trucks, trailers, and other vehicles and accessories.	X
26. Boats, motors, and accessories.	X
27. Aircraft and accessories.	X
		Subtotal (Total on this page)		$	0

Page 5 of 7


In re: Vermillion Inc.		Case No. 09-11091

Schedule B — Exhibit 1

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

016866-008110 US

National Phase of PCT/US02/28152

10/487,978

Feb 27, 2004

Aug 30, 2001

METHOD OF DIAGNOSING NEPHROTIC SYNDROME

Naohisa TOMOSUGI

ISSUED

US 2005-0260678 A1

Nov 24, 2005

7,297,556

Nov 20, 2007

Dec 24, 2023

016866-011550 EP

National Phase of PCT/US2004/37994

04810948.2

Nov 06, 2004

Nov 07, 2003

BIOMARKERS FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, James Norton McGUIRE, Anja Hviid SIMONSEN, Kaj BLENNOW, and Vladimir N. PODUST

PENDING

EP 1694816 A2

Aug 30, 2006

Nov 06, 2024

016866-011550 JP

National Phase of PCT/US2004/37994

2006-538558

Nov 06, 2004

Nov 07, 2003

BIOMARKERS FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, James Norton McGUIRE, Anja Hviid SIMONSEN, Kaj BLENNOW, and Vladimir N. PODUST

PENDING

Nov 06, 2024

016866-011550 US

Claims Priority from 60/518,360, 60/526,753, 60/546,423 (012600), 60/547,250, 60/558,896 (012610), 60/572,617, and 60/586,503

10/982,545

Nov 06, 2004

Nov 07, 2003

BIOMARKERS FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, James Norton McGUIRE, Anja Hviid SIMONSEN, Kaj BLENNOW, and Vladimir N. PODUST

PENDING

US 2005-0244890 A1

Nov 03, 2005

Nov 06, 2024

016866-015110 AU

National Phase of PCT/US2005/18728

2005253081

May 26, 2005

Jun 03, 2004

BIOMARKERS FOR PERIPHERAL ARTERY DISEASE

Eric T. FUNG, John P. COOKE, Xiao-Ying MENG, Tai-Tung YIP, and Fujun ZHANG

PENDING — TTC to Req Exam in late Oct 2008

May 26, 2025

016866-015110 CA

National Phase of PCT/US2005/18728

2568976

May 26, 2005

Jun 03, 2004

BIOMARKERS FOR PERIPHERAL ARTERY DISEASE

Eric T. FUNG, John P. COOKE, Xiao-Ying MENG, Tai-Tung YIP, and Fujun ZHANG

PENDING

May 26, 2025

016866-015110 CN

National Phase of PCT/US2005/18728

200580026416.x

May 26, 2005

Jun 03, 2004

BIOMARKERS FOR PERIPHERAL ARTERY DISEASE

Eric T. FUNG, John P. COOKE, Xiao-Ying MENG, Tai-Tung YIP, and Fujun ZHANG

PENDING

CN 101002084A

Jul 18, 2007

May 26, 2025

016866-015110 EP

National Phase of PCT/US2005/18728

05753615.3

May 26, 2005

Jun 03, 2004

BIOMARKERS FOR PERIPHERAL ARTERY DISEASE

Eric T. FUNG, John P. COOKE, Xiao-Ying MENG, Tai-Tung YIP, and Fujun ZHANG

PENDING

EP 1756554 A1

Feb 28, 2007

May 26, 2025

016866-015110 HK

Based on EP 05753615.3

07109214.4

May 26, 2005

Jun 03, 2004

BIOMARKERS FOR PERIPHERAL ARTERY DISEASE

Eric T. FUNG, John P. COOKE, Xiao-Ying MENG, Tai-Tung YIP, and Fujun ZHANG

PENDING

May 26, 2025

016866-015110 JP

National Phase of PCT/US2005/18728

2007-515387

May 26, 2005

Jun 03, 2004

BIOMARKERS FOR PERIPHERAL ARTERY DISEASE

Eric T. FUNG, John P. COOKE, Xiao-Ying MENG, Tai-Tung YIP, and Fujun ZHANG

PENDING

May 26, 2025

016866-015110 US

National Phase of PCT/US2005/18728

11/597,667

Nov 22, 2006

Jun 03, 2004

BIOMARKERS FOR PERIPHERAL ARTERY DISEASE

Eric T. FUNG, John P. COOKE, Xiao-Ying MENG, Tai-Tung YIP, and Fujun ZHANG

PENDING

May 26, 2025

Page 1 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

016866-018010 EP

Claims Priority from PCT/US2006/13727

06749933.5

Apr 11, 2006

Apr 19, 2005

SAPOSIN D AND FAM3C ARE BIOMARKERS FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, Kaj BLENNOW, James McGUIRE, Vladimir PODUST, and Anja Hviid SIMONSEN

PENDING — Seq List filed in Jun 2008

Apr 11, 2026

016866-018010 HK

Claims Priority from PCT/US2006/13727

Apr 11, 2006

Apr 19, 2005

SAPOSIN D AND FAM3C ARE BIOMARKERS FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, Kaj BLENNOW, James McGUIRE, Vladimir PODUST, and Anja Hviid SIMONSEN

PENDING

Apr 11, 2026

016866-018010 JP

Claims Priority from PCT/US2006/13727

2008-507718

Apr 11, 2006

Apr 19, 2005

SAPOSIN D AND FAM3C ARE BIOMARKERS FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, Kaj BLENNOW, James McGUIRE, Vladimir PODUST, and Anja Hviid SIMONSEN

PENDING

Apr 11, 2026

016866-018010 US

Claims Priority from PCT/US2006/13727

11/911,962

Oct 18, 2007

Apr 19, 2005

SAPOSIN D AND FAM3C ARE BIOMARKERS FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, Kaj BLENNOW, James McGUIRE, Vladimir PODUST, and Anja Hviid SIMONSEN

PENDING — Seq List filed in Jun 2008; awaiting first OA

Apr 11, 2026

016866-018110 EP

National Phase of
PCT/US2006/23044

06784840.8

Jun 13, 2006

Jun 16, 2005

FRAGMENT OF NEUROSECRETORY PROTEIN VGF AS A BIOMARKER FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, Kaj BLENNOW, James McGUIRE, Vladimir N. PODUST, and Anja Hviid SIMONSEN

PENDING

WO 2006/138325 A2

Dec 28, 2006

Jun 13, 2026

016866-018110 HK

National Phase of
PCT/US2006/23044

08104640.8

Jun 13, 2006

Jun 16, 2005

FRAGMENT OF NEUROSECRETORY PROTEIN VGF AS A BIOMARKER FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, Kaj BLENNOW, James McGUIRE, Vladimir N. PODUST, and Anja Hviid SIMONSEN

PENDING

WO 2006/138325 A2

Dec 28, 2006

Jun 13, 2026

016866-018110 JP

National Phase of
PCT/US2006/23044

2008-517032

Jun 13, 2006

Jun 16, 2005

FRAGMENT OF NEUROSECRETORY PROTEIN VGF AS A BIOMARKER FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, Kaj BLENNOW, James McGUIRE, Vladimir N. PODUST, and Anja Hviid SIMONSEN

PENDING

WO 2006/138325 A2

Dec 28, 2006

Jun 13, 2026

016866-018110 US

Claims Priority from
60/691,637(018100), CIP of
PCT/US06/13727 (018010), and CIP
of 10/982,545 (011550)

11/452,477

Jun 13, 2006

Jul 08, 2004

NEUROSECRETORY PROTEIN VGF AS A BIOMARKER FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, Kaj BLENNOW, James McGUIRE, Vladimir N. PODUST, and Anja Hviid SIMONSEN

PENDING — Resp to first OA filed in Jun 2008

US 2007-015221 A1

Jan 18, 2007

Nov 06, 2024

016866-018710 PC

Claims Priority from
60/779,246

PCT/US2007/63078

Mar 01, 2007

Mar 03, 2006

METHOD FOR QUANTIFYING AN ANALYTE IN A BIOLOGICAL SAMPLE USING MASS SPECTROMETRY

Lee O. LOMAS and
Egisto BOSCHETTI

PENDING; enters national phase on 9/3/08

WO 2007/103734 A2

Dec 06, 2007

Sep 03, 2008

016866-018820 PC

Claims Priority from
60/781,403 and 60/863,951

PCT/US2007/006276

Mar 12, 2007

Mar 11, 2006

BETA-2 MICROGLOBULIN AS A BIOMARKER FOR PERIPHERAL ARTERY DISEASE

John COOKE, Eric T. FUNG, and Eiichiro KIMURA

PENDING; enters national phase on 9/11/08

WO 2007/106466 A2

Sep 20, 2007

Sep 11, 2008

016866-018820 US

Claims Priority from
60/781,403 and 60/863,951

11/685,146

Mar 12, 2007

Mar 11, 2006

BETA-2 MICROGLOBULIN AS A BIOMARKER FOR PERIPHERAL ARTERY DISEASE

John COOKE, Eric T. FUNG, and Eiichiro KIMURA

PENDING

Mar 12, 2027

Page 2 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

016866-019900 PC

Claims Priority from 60/863,951

PCT/US2007/82730

Oct 26, 2007

Nov 01, 2006

A PANEL OF BIOMARKERS FOR PERIPHERAL ARTERIAL DISEASE

Eric T. FUNG, John COOKE, Fujun ZHANG, and Andrew WILSON

PENDING; enters national phase on 5/1/09

May 01, 2009

016866-019900 US

Claims Priority from 60/863,951

11/925,678

Oct 26, 2007

Nov 01, 2006

A PANEL OF BIOMARKERS FOR PERIPHERAL ARTERIAL DISEASE

Eric T. FUNG, John COOKE, Fujun ZHANG, and Andrew M. WILSON

PENDING

Oct 26, 2027

016866-019910 PC

Claims Priority from 60/863,951

PCT/US2007/83377

Nov 01, 2007

Nov 01, 2006

PANEL OF BIOMARKERS FOR PERIPHERAL ARTERIAL DISEASE

Eric T. FUNG, John COOKE, Fujun ZHANG, and Andrew WILSON

PENDING; enters national phase on 5/1/09

May 01, 2009

016866-019910 US

Claims Priority from 60/863,951

11/934,008

Nov 01, 2007

Nov 01, 2006

PANEL OF BIOMARKERS FOR PERIPHERAL ARTERIAL DISEASE

Eric T. FUNG, John COOKE, Fujun ZHANG, and Andrew M. WILSON

PENDING

Nov 01, 2027

S06-406 STAN524

60946681

Jun 27, 2007

B2m and CRP for PAD

John Cooke and Andrew Wilson

PENDING

021996-000200 CA (Biosite)

National Phase of PCT/US2004/12067

2522709

Apr 19, 2004

Apr 17, 2003

POLYPEPTIDES RELATED TO NATRIURETIC PEPTIDES AND METHODS OF THEIR IDENTIFICATION AND USE

Kenneth F. BUECHLER, Eric T. FUNG, and Tai-Tung YIP

PENDING

CA 2522709 AA

Nov 04, 2004

Apr 19, 2024

021996-000200 EP (Biosite)

National Phase of PCT/US2004/12067

04750349.5

Apr 19, 2004

Apr 17, 2003

POLYPEPTIDES RELATED TO NATRIURETIC PEPTIDES AND METHODS OF THEIR IDENTIFICATION AND USE

Kenneth F. BUECHLER, Eric T. FUNG, and Tai-Tung YIP

PENDING

EP 01616181 A2

Jan 18, 2006

Apr 19, 2024

021996-000200 JP (Biosite)

National Phase of PCT/US2004/12067

2006-513130

Apr 19, 2004

Apr 17, 2003

POLYPEPTIDES RELATED TO NATRIURETIC PEPTIDES AND METHODS OF THEIR IDENTIFICATION AND USE

Kenneth F. BUECHLER, Eric T. FUNG, and Tai-Tung YIP

PENDING

JP 2006-527190

Nov 30, 2006

Apr 19, 2024

021996-000200 US (Biosite)

CIP of 10/419,059 (filed Apr 17, 2003 by Biosite) and 60/466,358 (CIPH-0002)

10/827,919

Apr 19, 2004

Apr 17, 2003

POLYPEPTIDES RELATED TO NATRIURETIC PEPTIDES AND METHODS OF THEIR IDENTIFICATION AND USE

Kenneth F. BUECHLER, Eric T. FUNG, and Tai-Tung YIP

Granted

US 2005-064511 A1

Mar 24, 2005

Issued

Apr 17, 2023

021996-000210 US (Biosite)

DIV of 10/827,919

12/013,606

Jan 14, 2007

Apr 17, 2003

POLYPEPTIDES RELATED TO NATRIURETIC PEPTIDES AND METHODS OF THEIR IDENTIFICATION AND USE

Kenneth F. BUECHLER, Eric T. FUNG, and Tai-Tung YIP

PENDING

Apr 17, 2023

035394-001610 CN

National Phase of PCT/US03/10489

03809631.5

Oct 29, 2004

Apr 08, 2002

SERUM BIOMARKERS IN HEPATOCELLULAR CARCINOMA

Tai-Tung YIP, Terence POON, Philip JOHNSON, Victor F. YIP, Christine L. YIP, and Anthony CHAN

PENDING

CN 1649613 A

Aug 03, 2005

Apr 07, 2023

035394-001610 EP

National Phase of PCT/US03/10489

03746616.6

Apr 07, 2003

Apr 08, 2002

SERUM BIOMARKERS IN HEPATOCELLULAR CARCINOMA

Tai-Tung YIP, Terence POON, Philip JOHNSON, Victor F. YIP, Christine L. YIP, and Anthony CHAN

PENDING

EP 1496928

Jan 19, 2005

Apr 07, 2023

035394-001610 HK

Validated from EP 03746616.6

05105696.1

Apr 07, 2003

Apr 08, 2002

SERUM BIOMARKERS IN HEPATOCELLULAR CARCINOMA

Tai-Tung YIP, Terence POON, Philip JOHNSON, Victor F. YIP, Christine L. YIP, and Anthony CHAN

PENDING

Apr 07, 2023

Page 3 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

035394-001610 JP

National Phase of PCT/US03/10489

2003-583463

Oct 06, 2004

Apr 08, 2002

SERUM BIOMARKERS IN HEPATOCELLULAR CARCINOMA

Tai-Tung YIP, Terence POON, Philip JOHNSON, Victor F. YIP, Christine L. YIP, and Anthony CHAN

PENDING

JP 2005-522677

Jul 28, 2005

Apr 07, 2023

035394-001610 US

National Phase of PCT/US03/10489

10/508,781

Sep 23, 2004

Apr 08, 2002

SERUM BIOMARKERS IN HEPATOCELLULAR CARCINOMA

Tai-Tung YIP, Terence POON, Philip JOHNSON, Victor F. YIP, Christine L. YIP, and Anthony CHAN

PENDING

US 2006-084059 A1

Apr 20, 2006

Apr 07, 2023

035394-001910 EP

National Phase of PCT/US2003/36120

03783358.9

Nov 13, 2003

Nov 14, 2002

BIOMARKERS FOR INTRA-AMNIOTIC INFLAMMATION

Irina BUHIMSCHI and Robert CHRISTNER

PENDING

EP 0 1578205 A2

Sep 28, 2005

Nov 13, 2023

035394-001910 US

National Phase of PCT/US2003/36120

10/534,694

Jan 17, 2006

Nov 14, 2002

BIOMARKERS FOR INTRA-AMNIOTIC INFLAMMATION

Irina A. BUHIMSCHI and Robert CHRISTNER

PENDING

US 2006-127962 A1

Jun 15, 2006

Nov 13, 2023

035394-002210 EP

National Phase of PCT/US2003/36118

03783356.3

Nov 13, 2003

Feb 05, 2003

NON-INVASIVE ASSESSMENT OF INTRA-AMNIOTIC ENVIRONMENT

Irina A. BUHIMSCHI, Robert CHRISTNER, Catalin S. BUHIMSCHI, and Carl P. WEINER

PENDING

EP 01590664 A1

Nov 02, 2005

Nov 13, 2023

035394-002210 US

National Phase of PCT/US2003/36118

10/541,793

Apr 24, 2006

Feb 05, 2003

NON-INVASIVE ASSESSMENT OF INTRA-AMNIOTIC ENVIRONMENT

Irina A. BUHIMSCHI, Robert CHRISTNER, Catalin S. BUHIMSCHI, and Carl P. WEINER

PENDING

US 2006-0240495 A1

Oct 26, 2006

Nov 13, 2023

035394-002410 US

National Phase of PCT/US2004/17624

10/559,687

May 11, 2006

Jun 06, 2003

SERUM BIOMARKERS IN ISCHAEMIC HEART DISEASE

Jian (“Jane”) DING and Lee O. LOMAS

PENDING

US 2006-0257946 A1

Nov 16, 2006

Jun 04, 2024

035394-003810 EP

National Phase of PCT/US2006/023954

Jun 20, 2006

Jun 21, 2005

BIOMARKERS FOR BREAST CANCER

Anthony GONÇALVES, Jean-Paul BORG, Eric Thomas FUNG, and Xiao-Ying MENG

PENDING

Jun 20, 2026

035394-003810 US

National Phase of PCT/US2006/023954

11/917,766

Dec 16, 2007

Jun 21, 2005

BIOMARKERS FOR BREAST CANCER

Anthony GONÇALVES, Jean-Paul BORG, Eric Thomas FUNG, and Xiao-Ying MENG

PENDING

Jun 20, 2026

035394-004310 US (formerly OSU-000110 US)

ORIGINAL FILING

11/711,946

Feb 27, 2007

Feb 27, 2006

PROCESS TO DETERMINE ENZYME ACTIVITY

Haifeng WU, Ming JIN, Michael BISSELL and Spero CATALAND

PENDING

Feb 27, 2027

EAPD-56792 US (71699) (JHU)

National Phase of PCT/US03/00531

10/500,838

Feb 02, 2005

Jan 07, 2002

BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, and Alex Jaideep RAI

PENDING

US 2005-214760 A1

Sep 29, 2005

Jan 07, 2023

EAPD-57203 CA (71699) (JHU)

National Phase of PCT/US03/06850

2,478,036

Mar 06, 2003

Mar 06, 2002

USE OF BIOMARKERS TO DETECT BREAST CANCER

Daniel W. CHAN, Zhen ZHANG, and Jinong LI

PENDING

Mar 06, 2023

EAPD-57203 EP (71699) (JHU)

National Phase of PCT/US03/06850

03713930.0

Mar 06, 2003

Mar 06, 2002

USE OF BIOMARKERS TO DETECT BREAST CANCER

Daniel W. CHAN, Zhen ZHANG, and Jinong LI

PENDING

EP 1585962

Oct 19, 2005

Mar 06, 2023

EAPD-57203 JP (71699) (JHU)

National Phase of PCT/US03/06850

2003-575071

Mar 06, 2003

Mar 06, 2002

USE OF BIOMARKERS TO DETECT BREAST CANCER

Daniel W. CHAN, Zhen ZHANG, and Jinong LI

PENDING

JP 2006-508326

Mar 09, 2006

Mar 06, 2023

EAPD-57203 US (71699) (JHU)

National Phase of PCT/US03/06850

10/506,725

Sep 04, 2004

Mar 06, 2002

USE OF BIOMARKERS TO DETECT BREAST CANCER

Daniel W. CHAN, Zhen ZHANG, and Jinong LI

PENDING

US 2005-170352 A1

Aug 04, 2005

Mar 06, 2023

EAPD-57222 EP (71699) (JHU)

National Phase of PCT/US2003/12729

03724209.6

Oct 25, 2004

Apr 26, 2002

IDENTIFICATION OF BIOMARKERS FOR DETECTING PROSTATE CANCER

Daniel W. CHAN, Jinong LI, and Zhen ZHANG

PENDING

Apr 25, 2023

Page 4 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

EAPD-57222 US (71699) (JHU)

National Phase of PCT/US03/12729

10/512,731

Oct 26, 2004

Apr 26, 2002

IDENTIFICATION OF BIOMARKERS FOR DETECTING PROSTATE CANCER

Daniel W. CHAN,
Jinong LI, and Zhen ZHANG

PENDING

US 2005-176011 A1

Aug 11, 2005

Apr 25, 2023

EAPD-58368 AU (71699) (JHU)

National Phase of PCT/US2003/024659

2003256858

Aug 05, 2003

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

AU 03257207

Feb 23, 2004

Aug 05, 2023

EAPD-58368 CA (71699) (JHU)

National Phase of PCT/US2003/024659

2493817

Jan 27, 2005

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

Aug 05, 2023

EAPD-58368 CN (71699) (JHU)

National Phase of PCT/US2003/024659

03819042.7

Aug 05, 2003

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

CN 1675372 A

Sep 28, 2005

Aug 05, 2023

EAPD-58368 EP (71699) (JHU)

National Phase of PCT/US2003/024659

03767259.9

Aug 05, 2003

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

EP 1540010

Jun 15, 2005

Aug 05, 2023

EAPD-58368 HK (71699) (JHU)

Validated from EP 03767259.9

05111072.3

Dec 05, 2005

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

HK 1076489 A

Jan 20, 2006

Aug 05, 2023

EAPD-58368 IL (71699) (JHU)

National Phase of PCT/US2003/024659

166118

Jan 03, 2005

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

Aug 05, 2023

EAPD-58368 JP (71699) (JHU)

National Phase of PCT/US2003/024659

2005-506102

Aug 05, 2003

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

Aug 05, 2023

EAPD-58368 KR (71699) (JHU)

National Phase of PCT/US2003/24659

10-2005-7001536

Jan 27, 2005

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

Aug 05, 2023

EAPD-58368 US (71699) (JHU)

Claims Priority from 60/401,837, 60/441,727, and 60/460,342

10/635,308

Aug 05, 2003

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

US 2005-059013 A1

Mar 17, 2005

Aug 05, 2023

EAPD-58368-DIV NZ (71699) (JHU)

DIV of 538236

562912

Aug 05, 2003

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

Aug 05, 2023

EAPD-61154 AU (71699) (JHU)

National Phase of PCT/US05/10783

2005-230445

Mar 31, 2005

Mar 31, 2004

BIOMARKERS FOR OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG , and Xiao-Ying MENG

PENDING

Mar 31, 2025

EAPD-61154 CA (71699) (JHU)

National Phase of PCT/US05/10783

2,559,911

Mar 31, 2005

Mar 31, 2004

BIOMARKERS FOR OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG , and Xiao-Ying MENG

PENDING

Mar 31, 2025

EAPD-61154 CN (71699) (JHU)

National Phase of PCT/US05/10783

200580017610.1

Mar 31, 2005

Mar 31, 2004

BIOMARKERS FOR OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG , and Xiao-Ying MENG

PENDING

CN 101023349 A

Aug 22, 2007

Mar 31, 2025

EAPD-61154 EP (71699) (JHU)

National Phase of PCT/US05/10783

05740120

Mar 31, 2005

Mar 31, 2004

BIOMARKERS FOR OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG , and Xiao-Ying MENG

PENDING

EP 1756566 A2

Feb 28, 2007

Mar 31, 2025

EAPD-61154 JP (71699) (JHU)

National Phase of PCT/US05/10783

2007-506525

Mar 31, 2005

Mar 31, 2004

BIOMARKERS FOR OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG , and Xiao-Ying MENG

PENDING

2007-531883 A

Nov 08, 2007

Mar 31, 2025

Page 5 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

EAPD-61154 US (71699) (JHU)

National Phase of PCT/US05/10783

10/594,874

Sep 28, 2006

Mar 31, 2004

BIOMARKERS FOR OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG , and Xiao-Ying MENG

PENDING

Mar 31, 2025

EAPD-61849 AU (71699) (JHU)

National Phase of PCT/US05/33168

2005287074

Sep 16, 2005

Sep 17, 2004

BIOMARKERS FOR BREAST CANCER

Jinong LI, Carolyn Nicole WHITE, Zhen ZHANG, Daniel W. CHAN, Eric Thomas FUNG, and Xiao-Ying MENG

PENDING

Sep 16, 2025

EAPD-61849 CA (71699) (JHU)

National Phase of PCT/US05/33168

2,580,494

Sep 16, 2005

Sep 17, 2004

BIOMARKERS FOR BREAST CANCER

Jinong LI, Carolyn Nicole WHITE, Zhen ZHANG, Daniel W. CHAN, Eric Thomas FUNG, and Xiao-Ying MENG

PENDING

Sep 16, 2025

EAPD-61849 CN (71699) (JHU)

National Phase of PCT/US05/33168

200580039464.2

Sep 16, 2005

Sep 17, 2004

BIOMARKERS FOR BREAST CANCER

Jinong LI, Carolyn Nicole WHITE, Zhen ZHANG, Daniel W. CHAN, Eric Thomas FUNG, and Xiao-Ying MENG

PENDING

Sep 16, 2025

EAPD-61849 EP (71699) (JHU)

National Phase of PCT/US05/33168

05800204.9

Sep 16, 2005

Sep 17, 2004

BIOMARKERS FOR BREAST CANCER

Jinong LI, Carolyn Nicole WHITE, Zhen ZHANG, Daniel W. CHAN, Eric Thomas FUNG, and Xiao-Ying MENG

PENDING

EP 1802764 A2

Jul 04, 2007

Sep 16, 2025

EAPD-61849 MX (71699) (JHU)

National Phase of PCT/US05/33168

MX/a/2007/003003

Sep 16, 2005

Sep 17, 2004

BIOMARKERS FOR BREAST CANCER

Jinong LI, Carolyn Nicole WHITE, Zhen ZHANG, Daniel W. CHAN, Eric Thomas FUNG, and Xiao-Ying MENG

PENDING

Sep 16, 2025

EAPD-61849 US (71699) (JHU)

National Phase of PCT/US05/33168

11/662,830

Mar 13, 2007

Sep 17, 2004

BIOMARKERS FOR BREAST CANCER

Jinong LI, Carolyn Nicole WHITE, Zhen ZHANG, Daniel W. CHAN, Eric Thomas FUNG, and Xiao-Ying MENG

PENDING

Sep 16, 2025

EAPD-62959 AU (71699) (JHU)

National Phase of PCT/US2006/08578

2006223374

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

AU 6223374 AA

Sep 21, 2006

Mar 10, 2026

EAPD-62959 CA (71699) (JHU)

National Phase of PCT/US2006/08578

2,602,088

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

2,602,088 AA

Sep 21, 2006

Mar 10, 2026

EAPD-62959 CN (71699) (JHU)

National Phase of PCT/US2006/08578

2006-80007808.6

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

Mar 10, 2026

EAPD-62959 EP (71699) (JHU)

National Phase of PCT/US2006/08578

06737729.1

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

EP 1 869 462

Dec 26, 2007

Mar 10, 2026

EAPD-62959 IL (71699) (JHU)

National Phase of PCT/US2006/08578

185496

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

Mar 10, 2026

Page 6 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

EAPD-62959 JP (71699) (JHU)

National Phase of PCT/US2006/08578

2008-500963

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

Mar 10, 2026

EAPD-62959 KR (71699) (JHU)

National Phase of PCT/US2006/08578

10-2007-7023307

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

Mar 10, 2026

EAPD-62959 MX (71699) (JHU)

National Phase of PCT/US2006/08578

MX/a/2007/011024

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

Mar 10, 2026

EAPD-62959 NZ (71699) (JHU)

National Phase of PCT/US2006/08578

560976

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

Mar 10, 2026

EAPD-62959 US (71699) (JHU)

Claims Priority from 60/662,090

11/373,833

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

US 2007-0054329 A1

Mar 08, 2007

Mar 10, 2026

EAPD-63133 CA (71699) (JHU)

National Phase of PCT/US2006/020643

2,608,522

May 25, 2006

May 26, 2005

BIOMARKERS FOR BREAST CANCER

Jinong LI, Saraswati SUKUMAR, and Daniel W. CHAN

PENDING

May 25, 2026

EAPD-63133 CN (71699) (JHU)

National Phase of PCT/US2006/020643

2006-80026379.7

May 25, 2006

May 26, 2005

BIOMARKERS FOR BREAST CANCER

Jinong LI, Saraswati SUKUMAR, and Daniel W. CHAN

PENDING

May 25, 2026

EAPD-63133 EP (71699) (JHU)

National Phase of PCT/US2006/020643

06771418.8

May 25, 2006

May 26, 2005

BIOMARKERS FOR BREAST CANCER

Jinong LI, Saraswati SUKUMAR, and Daniel W. CHAN

PENDING

May 25, 2026

EAPD-63133 MX (71699) (JHU)

National Phase of PCT/US2006/020643

MX/A/2007/014863

May 25, 2006

May 26, 2005

BIOMARKERS FOR BREAST CANCER

Jinong LI, Saraswati SUKUMAR, and Daniel W. CHAN

PENDING

May 25, 2026

EAPD-63133 US (71699) (JHU)

National Phase of PCT/US2006/020643

11/920,906

Nov 21, 2007

May 26, 2005

BIOMARKERS FOR BREAST CANCER

Jinong LI, Saraswati SUKUMAR, and Daniel W. CHAN

PENDING

May 25, 2026

EAPD-63630 AU (52903) (VRML)

National Phase of PCT/US2006/024677

2006261904

Jun 23, 2006

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER: β-2 MICROGLOBULIN

Eric T. FUNG, Enrique DALMASSO, Valdimir PODUST, and Zheng WANG

PENDING

Jun 23, 2026

EAPD-63630 CA (52903) (VRML)

National Phase of PCT/US2006/024677

2,611,524

Jun 23, 2006

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER: β-2 MICROGLOBULIN

Eric T. FUNG, Enrique DALMASSO, Valdimir PODUST, and Zheng WANG

PENDING

Jun 23, 2026

EAPD-63630 EP (52903) (VRML)

National Phase of PCT/US2006/024677

06785526.2

Jun 23, 2006

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER: β-2 MICROGLOBULIN

Eric T. FUNG, Enrique DALMASSO, Valdimir PODUST, and Zheng WANG

PENDING

EP 1 904 852

Apr 02, 2008

Jun 23, 2026

EAPD-63630 IL (52903) (VRML)

National Phase of PCT/US2006/024677

187899

Dec 04, 2007

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER: β-2 MICROGLOBULIN

Eric T. FUNG, Enrique DALMASSO, Valdimir PODUST, and Zheng WANG

PENDING

Jun 23, 2026

EAPD-63630 MX (52903) (VRML)

National Phase of PCT/US2006/024677

MX/a/2008/000098

Jun 23, 2006

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER: β-2 MICROGLOBULIN

Eric T. FUNG, Enrique DALMASSO, Valdimir PODUST, and Zheng WANG

PENDING

Jun 23, 2026

EAPD-63630 US (52903) (VRML)

National Phase of PCT/US2006/024677

11/922,621

Dec 20, 2007

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER: β-2 MICROGLOBULIN

Eric T. FUNG, Enrique DALMASSO, Valdimir PODUST, and Zheng WANG

PENDING

Jun 23, 2026

Page 7 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

EAPD-63631 AU (71699) (JHU)

National Phase of PCT/US2006/024269

2006262182

Jun 21, 2006

Jun 22, 2005

BIOMARKER FOR OVARIAN CANCER: CTAP3-RELATED PROTEINS

Zhen ZHANG, Daniel Wanyui CHAN, Eric T. FUNG, Zheng WANG, and Fujun ZHANG

PENDING

Jun 21, 2026

EAPD-63631 CA (71699) (JHU)

National Phase of PCT/US2006/024269

2,611,340

Jun 21, 2006

Jun 22, 2005

BIOMARKER FOR OVARIAN CANCER: CTAP3-RELATED PROTEINS

Zhen ZHANG, Daniel Wanyui CHAN, Eric T. FUNG, Zheng WANG, and Fujun ZHANG

PENDING

Jun 21, 2026

EAPD-63631 CN (71699) (JHU)

National Phase of PCT/US2006/024269

2006-80029695.x

Jun 21, 2006

Jun 22, 2005

BIOMARKER FOR OVARIAN CANCER: CTAP3-RELATED PROTEINS

Zhen ZHANG, Daniel Wanyui CHAN, Eric T. FUNG, Zheng WANG, and Fujun ZHANG

PENDING

Jun 21, 2026

EAPD-63631 EP (71699) (JHU)

National Phase of PCT/US2006/024269

06785323.4

Jun 21, 2006

Jun 22, 2005

BIOMARKER FOR OVARIAN CANCER: CTAP3-RELATED PROTEINS

Zhen ZHANG, Daniel Wanyui CHAN, Eric T. FUNG, Zheng WANG, and Fujun ZHANG

PENDING

Jun 21, 2026

100

EAPD-63631 IL (71699) (JHU)

National Phase of PCT/US2006/024269

187867

Jun 21, 2006

Jun 22, 2005

BIOMARKER FOR OVARIAN CANCER: CTAP3-RELATED PROTEINS

Zhen ZHANG, Daniel Wanyui CHAN, Eric T. FUNG, Zheng WANG, and Fujun ZHANG

PENDING

Jun 21, 2026

101

EAPD-63631 JP (71699) (JHU)

National Phase of PCT/US2006/024269

2008-518376

Jun 21, 2006

Jun 22, 2005

BIOMARKER FOR OVARIAN CANCER: CTAP3-RELATED PROTEINS

Zhen ZHANG, Daniel Wanyui CHAN, Eric T. FUNG, Zheng WANG, and Fujun ZHANG

PENDING

Jun 21, 2026

102

EAPD-63631 MX (71699) (JHU)

National Phase of PCT/US2006/024269

MX/a/2008/000090

Jun 21, 2006

Jun 22, 2005

BIOMARKER FOR OVARIAN CANCER: CTAP3-RELATED PROTEINS

Zhen ZHANG, Daniel Wanyui CHAN, Eric T. FUNG, Zheng WANG, and Fujun ZHANG

PENDING

Jun 21, 2026

103

EAPD-63631 US (71699) (JHU)

Claims Priority from 60/693,324

11/473,280

Jun 21, 2006

Jun 22, 2005

BIOMARKER FOR OVARIAN CANCER

Zhen ZHANG, Daniel Wanyui CHAN, Eric T. FUNG, Zheng WANG, and Fujun ZHANG

PENDING

US 2007-0172902 A1

Jul 26, 2007

Jun 21, 2026

104

EAPD-64161 AU (71699) (JHU)

Natl phase of PCT/US/2006/036538

2006-292212

Sep 19, 2006

Sep 19, 2005

BIOMARKER FOR PROSTATE CANCER

Zhen ZHANG, Daniel W. CHAN, and Carolyn ROSENZWEIG

PENDING; enters national phase by 3/19/08

Sep 19, 2026

105

EAPD-64161 CN (71699) (JHU)

Natl phase of PCT/US/2006/036538

Sep 19, 2006

Sep 19, 2005

BIOMARKER FOR PROSTATE CANCER

Zhen ZHANG, Daniel W. CHAN, and Carolyn ROSENZWEIG

PENDING; enters national phase by 3/19/08

Sep 19, 2026

106

EAPD-64161 EP (71699) (JHU)

Natl phase of PCT/US/2006/036538

06803875.1

Sep 19, 2006

Sep 19, 2005

BIOMARKER FOR PROSTATE CANCER

Zhen ZHANG, Daniel W. CHAN, and Carolyn ROSENZWEIG

PENDING; enters national phase by 3/19/08

1934603

Jun 25, 208

Sep 19, 2026

107

EAPD-64161 JP (71699) (JHU)

Natl phase of PCT/US/2006/036538

Sep 19, 2006

Sep 19, 2005

BIOMARKER FOR PROSTATE CANCER

Zhen ZHANG, Daniel W. CHAN, and Carolyn ROSENZWEIG

PENDING; enters national phase by 3/19/08

Sep 19, 2026

108

EAPD-64161 US (71699) (JHU)

Natl phase of PCT/US/2006/036538

11/922,000

Mar 12, 2008

Sep 19, 2005

BIOMARKER FOR PROSTATE CANCER

Zhen ZHANG, Daniel W. CHAN, and Carolyn ROSENZWEIG

PENDING; enters national phase by 3/19/08

Sep 19, 2026

109

EAPD-66375 PC (71699) (JHU)

Claims Priority from 60/849,506

PCT/US2007/021483

Oct 04, 2007

Oct 04, 2006

ALGORITHIMS FOR MULTIVARIANT MODELS TO COMBINE A PANEL OF BIOMARKERS FOR ASSESSING THE RISK OF DEVELOPING OVARIAN CANCER

Zhen ZHANG

PENDING; enters national phase by 4/4/09

Apr 04, 2009

Page 8 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

110

EAPD-66453 P2 (52903) (VRML)

ORIGINAL FILING

60/998,728

Oct 12, 2007

PROGNOSTIC BIOMARKER IN PATIENTS WITH OVARIAN CANCER

Eric T. FUNG

PENDING

Oct 12, 2008

111

EAPD-66453 PC (52903) (VRML)

Claims Priority from 60/851,520

PCT/US2007/021867

Oct 12, 2007

Oct 13, 2006

PROGNOSTIC BIOMARKER IN PATIENTS WITH OVARIAN CANCER

Eric T. FUNG

PENDING; enters national phase by 4/13/09

Apr 13, 2009

112

EAPD-67896 P2 (52903) (VRML)

Second Provisonal, but doesn’t claim priority to 60/920,274; HOWEVER, both US regular and WO claim priority to both

61/034,469

Mar 06, 2008

BIOMARKERS FOR OVARIAN CANCER

Eric T. FUNG, Robert C. BAST, Vladimir PODUST, and Charlotte CLARK

PENDING; regular and PCT applications due 3/5/09

Mar 06, 2008

113

EAPD-67896 PC (52903) (VRML)

Claims priority to 60/920,274 and 61/034,469

PCT/US/2008/004088

Mar 27, 2008

Mar 27, 2007

BIOMARKERS FOR OVARIAN CANCER

Eric T. FUNG, Robert C. BAST, Vladimir PODUST, and Charlotte CLARK

PENDING; enters national phase by 9/26/09

Sep 27, 2009

114

EAPD-67896 US (52903) (VRML)

Claims priority to 60/920,274 and 61/034,469

12/079,592

Mar 27, 2008

Mar 27, 2007

BIOMARKERS FOR OVARIAN CANCER

Eric T. FUNG, Robert C. BAST, Vladimir PODUST, and Charlotte CLARK

PENDING

Mar 27, 2028

115

EAPD-68838 CA (52903) (VRML)

National Phase of PCT/US2006/024693

2,611,173

Jun 23, 2006

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER

Eric T. FUNG, Frederick Rand UELAND, J.R. van NAGELL, Jr., Paul Duane DEPRIEST, and Andre Thomas BARON

PENDING

Jun 23, 2026

116

EAPD-68838 CN (52903) (VRML)

National Phase of PCT/US2006/024693

Jun 23, 2006

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER

Eric T. FUNG, Frederick Rand UELAND, J.R. van NAGELL, Jr., Paul Duane DEPRIEST, and Andre Thomas BARON

PENDING

Jun 23, 2026

117

EAPD-68838 EP (52903) (VRML)

National Phase of PCT/US2006/024693

06773938.3

Jun 23, 2006

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER

Eric T. FUNG, Frederick Rand UELAND, J.R. van NAGELL, Jr., Paul Duane DEPRIEST, and Andre Thomas BARON

PENDING

Jun 23, 2026

118

EAPD-68838 JP (52903) (VRML)

National Phase of PCT/US2006/024693

2008-51847

Jun 23, 2006

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER

Eric T. FUNG, Frederick Rand UELAND, J.R. van NAGELL, Jr., Paul Duane DEPRIEST, and Andre Thomas BARON

PENDING

Jun 23, 2026

119

EAPD-68838 US (52903) (VRML)

National Phase of PCT/US2006/024693

11/922,652

Dec 20, 2007

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER

Eric T. FUNG, Frederick Rand UELAND, J.R. van NAGELL, Jr., Paul Duane DEPRIEST, and Andre Thomas BARON

PENDING

Jun 23, 2026

120

EAPD-68840 PC (52903) (VRML)

Based on 60/908,670

PCT/US2008/04089

Mar 27, 2008

Mar 28, 2007

METHODS FOR DIAGNOSING OVARIAN CANCER

Eric T. FUNG, Tai-Tung YIP, Vladimir PODUST, Mats BRÄNNSTRÖM, Karin SUNDFELDT, and Bjorg KRISJANSDOTTIR

PENDING; enters national phase by 9/27/09

Sep 28, 2009

Page 9 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

121

EAPD-68840 US (52903) (VRML)

Based on 60/908,670

12/079,588

Mar 27, 2008

Mar 28, 2007

METHODS FOR DIAGNOSING OVARIAN CANCER

Eric T. FUNG, Tai-Tung YIP, Vladimir PODUST, Mats BRÄNNSTRÖM, Karin SUNDFELDT, and Bjorg KRISJANSDOTTIR

PENDING

Mar 27, 2028

122

EAPD-69585 P
(52903) (VRML)

ORIGINAL FILING

60/983,378

Oct 29, 2007

METHODS FOR DIAGNOSING OVARIAN CANCER

Eric T. FUNG, Charlotte CLARK, Robert C. BAST, and Kevin COOMBES

PENDING; regular and PCT applications due 10/28/08

Oct 29, 2008

123

NCVC-000110 JP

National Phase of PCT/JP02/10816

Oct 18, 2002

SUBSTRATES SPECIFIC TO VON WILLEBRAND FACTOR CLEAVING PROTEASE AND METHOD OF ASSAYING THE ACTIVITY

Toshiyuki MIYATA and Koichi KOKAME

ISSUED

JP 3944586

Oct 18, 2022

124

NCVC-000110 US

National Phase of PCT/JP02/10816

10/531,427

Apr 15, 2005

Oct 18, 2002

SUBSTRATES SPECIFIC TO VON WILLEBRAND FACTOR CLEAVING PROTEASE AND METHOD OF ASSAYING THE ACTIVITY

Toshiyuki MIYATA and Koichi KOKAME

PENDING

US 2007-0065895 A1

Mar 22, 2007

Oct 18, 2022

125

VRML-0021 US

National Phase of PCT/US05/00548 (14)

10/586,075

Jul 14, 2006

Jan 16, 2004

SPECIFIC DETECTION OF TROPONIN AND MODIFIED FORMS OF TROPONIN

Tai-Tung YIP and Eric T. FUNG

PENDING

Jan 07, 2025

126

VRML-0023 PC

Claims Priority from 60/749,449

PCT/US2006/61954

Dec 12, 2006

Dec 12, 2005

BIOMARKERS FOR BABESIA

Momar NDAO, Brian WARD, Peter KRAUSE, Mark DUNCAN, Mike EDWARDS, and Terrence William SPITHILL

PENDING; enters national phase by 6/12/08

WO 2007/070809

Jun 21, 2007

Jun 12, 2008

127

VRML-0030 BR (formerly 016866-012130 BR)

National Phase of PCT/US2004/040990

PI 0417231-0

Jun 02, 2006

Dec 05, 2003

SERUM BIOMARKERS FOR CHAGAS DISEASE

Momar NDAO, Brian WARD, Rebecca E. CAFFREY, Terence William SPITHILL, Hongshan LI, Vladimir PODUST, and Regis PERICHON

PENDING

Dec 06, 2024

128

VRML-0031 CA (formerly 016866-012130 CA)

National Phase of PCT/US2004/040990

2547861

Dec 06, 2004

Dec 05, 2003

SERUM BIOMARKERS FOR CHAGAS DISEASE

Momar NDAO, Brian WARD, Rebecca E. CAFFREY, Terence William SPITHILL, Hongshan LI, Vladimir PODUST, and Regis PERICHON

PENDING

Dec 06, 2024

129

VRML-0032 EP (formerly 016866-012130 EP)

National Phase of PCT/US2004/040990

04813321.9

Dec 06, 2004

Dec 05, 2003

SERUM BIOMARKERS FOR CHAGAS DISEASE

Momar NDAO, Brian WARD, Rebecca E. CAFFREY, Terence William SPITHILL, Hongshan LI, Vladimir PODUST, and Regis PERICHON

PENDING

EP 1718763 A2

Nov 08, 2006

Dec 06, 2024

130

VRML-0033 MX (formerly 016866-012130 MX

National Phase of PCT/US2004/040990

PA/a/2006/006231

Dec 06, 2004

Dec 05, 2003

SERUM BIOMARKERS FOR CHAGAS DISEASE

Momar NDAO, Brian WARD, Rebecca E. CAFFREY, Terence William SPITHILL, Hongshan LI, Vladimir PODUST, and Regis PERICHON

PENDING

Dec 06, 2024

Page 10 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

131

VRML-0034 US (formerly 016866-012130 US)

Claims Priority from 60/527,153, 60/565,093, and 60/625,519

11/006,119

Dec 06, 2004

Dec 05, 2003

SERUM BIOMARKERS FOR CHAGAS DISEASE

Momar NDAO, Brian WARD, Rebecca E. CAFFREY, Terence William SPITHILL, Hongshan LI, Vladimir PODUST, and Regis PERICHON

PENDING

US 2005-260691 A1

Nov 24, 2005

Dec 06, 2024

132

VRML-0035 P

ORIGINAL FILING

60/985,611

Nov 05, 2007

BIOMARKERS FOR LEISHMANIASIS

Momar NDAO, Brian WARD, and Naomi ARONSON

PENDING; regular and PCT applications due by Nov 4, 2008

Nov 05, 2008

Page 11 of 11


In re: Vermillion, Inc.		Case No. 09-11091
Schedule B — Exhibit 3
Plant, Property, and Equipment
Detail Listing
March 31, 2009


System		Asset			Acquisition				Acquisition		Accumulated
Number		Tag			Date	Account		Description	Value		Depreciation		Net Book Value
	20		01011		01Sep97		1610	Centrifuge — Sorvall Super 21		14,252.50		14,252.50		0.00
	103		01777		27Mar00		1610	ST-H750 Rotor with Buckets		7,134.34		7,134.34		0.00
	146		01174		25May00		1610	Biomek 2000 Workstation		79,630.11		79,630.11		0.00
	269		01173		21Dec00		1610	Eppendorf Centrifuge 5417R		5,136.20		5,136.20		0.00
	297		01171		31Jan01		1610	Triple Swinging Door Refrigerator		5,694.47		5,694.47		0.00
	349		01021		30Apr01		1610	Balance PSLIP# 7638161-0		3,505.13		3,505.13		0.00
	352		01146		30Apr01		1610	XL1010 Sonicator with 1/2" Horn		5,646.28		5,646.28		0.00
	373		01148		30Jun01		1610	Model 5416 Feezer- 86 VWR-Revco		6,909.13		6,909.13		0.00
	415		01151		30Sep01		1610	Biomek 2000 Workstation		79,569.79		79,569.79		0.00
	416		01181		30Sep01		1610	Biomek 2000 Workstation w/Autoloader PAL03126		83,911.56		83,911.56		0.00
	501		01357		31Mar02		1610	Refrigerator, GLS Door, 72 Cubic Ft		4,503.53		4,503.53		0.00
	542		01847		07May02		1610	DPC Shaker Integ Kit/BMK 2000		3,274.32		3,274.32		0.00
	741		02150		14Jan03		1610	Freezer, UPRT, Val		8,427.77		8,427.77		0.00
	766		02077		26Feb03		1610	Micromix 5 Shaker		2,122.31		2,122.31		0.00
	780		02149		20Mar03		1610	Biological Safey Cabinet Class II A2		8,265.56		8,265.56		0.00
	934		02195	(?)	31Aug03		1610	NRE Tooling Charge for WIOS Wafter, 5"x5"		12,000.00		12,000.00		0.00
	977		02186		01Dec03		1610	Retrofit kits		24,059.65		24,059.65		0.00
	1,045		02115		23Mar04		1610	SPBSIIc		42,395.30		42,395.30		0.00
	1,067		02189		31Mar04		1610	DPC Micromix 5 Shaker		2,215.36		2,215.36		0.00
	1,084		02438		28Apr04		1610	Biomek 2000 Integration Package (Shaker)		5,585.70		5,585.70		0.00
	1,086		02110		28Apr04		1610	Biomek 2000 Integration Package (Shaker) Micromix 5		5,585.70		5,585.70		0.00
	1,200		02350		05Jan05		1610	FREEZER		8,775.00		7,166.25		1,608.75
	1,201		02351		05Jan05		1610	FREEZER		8,775.00		7,166.25		1,608.75
	1,210		02359		31Mar05		1610	QSTAR XL Mass Spectrometer		357,619.45		268,214.59		89,404.86
	1,215		02369		08Apr05		1610	PCS4000, PROTEINCHIP READER		47,407.55		47,407.55		0.00
	1,216		02370		08Apr05		1610	PCS4000		47,407.55		47,407.55		0.00
	1,219		02436		16Jun05		1610	Tandem MS Interface only QSTAR/Z200-0003		21,987.28		21,987.28		0.00
	1,241				31Oct05		1610	PCS4000 SN: 5E1151E		49,824.93		49,824.93		0.00
	1,258		02421		31Jan06		1610	BioDot AD1800 SN: AD1610		34,730.00		21,995.67		12,734.33
	1,264		02418		31Jan06		1610	PCS 4000 SN: 5I1170E		76,453.27		76,453.27		0.00
	1,268				12Apr06		1610	PCS4000 SN: 5K1182E		46,359.01		45,071.25		1,287.76
	1,285		02475		09Aug06		1610	PCS4000 SN: 6A1196E		47,631.29		41,015.84		6,615.45
	1,286		2463		10Aug06		1610	PCS4000 SN: 6C1198E		38,839.51		33,445.12		5,394.39
	1,288				10Aug06		1610	PCS4000 SN: 6A1190E		46,201.25		39,784.41		6,416.84
	1,290				10Oct06		1610	PBS11C SN: 4C637TC		37,159.84		29,934.31		7,225.53
	1,292		2476		31Oct06		1610	EVO 150 w/MCA Package with work station		108,879.39		52,625.04		56,254.35
	1,309				15Mar07		1610	Assy(refurbished), laser module		17,293.42		12,009.31		5,284.11
	1,312				01Nov04		1610	PCS4000		44,173.43		44,173.43		0.00
	1,317				15Jun07		1610	Assy(refurbished), laser module-reduction in price FA#1309		-1,151.92		-703.95		-447.97
	1,318		02467		31Oct07		1610	PCS 4000 SELDI Enterprise edition, w/Barcode scanner, data mgr&doc package		69,873.61		32,995.87		36,877.74
	1,319				14Sep07		1610	PCS 4000, LASER MODULE		16,185.69		8,542.44		7,643.25
	1,320		02468		31Oct07		1610	PCS 4000 SELDI Enterprise edition, w/Barcode scanner, data mgr&doc package		69,873.61		32,995.87		36,877.74
	1,322		02466		31Oct07		1610	PCS 4000 SELDI Enterprise edition, w/Barcode scanner, data mgr&doc package		69,873.61		32,995.87		36,877.74
	1,323		02469		31Oct07		1610	PCS 4000 SELDI Enterprise edition, w/Barcode scanner, data mgr&doc package		69,873.61		32,995.87		36,877.74


System		Asset		Acquisition				Acquisition		Accumulated
Number		Tag		Date	Account		Description	Value		Depreciation		Net Book Value
	1,324		02470	31Oct07		1610	PCS 4000 SELDI Enterprise edition, w/Barcode scanner, data mgr&doc package		69,873.62		32,995.88		36,877.74
	1,325		02471	03Oct07		1610	Scotsman model AFE400AE-1H flake ice machine		3,741.00		1,122.30		2,618.70
	1,326		02472	31Oct07		1610	Demo instrument freedom EVO 200 SN 491		100,565.48		47,489.25		53,076.23
	1,334		N/A	02Dec08		1610	BN II Nephelometer, #07235		47,562.50		2,378.12		45,184.38


									1,965,612.69		1,479,314.28		486,298.41
	163		01636	31Jul00		1620	HP Laser Jet 4050TN Printer		2,896.76		2,896.76		0.00
	164		01637	31Jul00		1620	HP Laser Jet 4050TN Printer		2,896.76		2,896.76		0.00
	165		01638	31Jul00		1620	HP Laserjet 4050TN Printer and Accessories		2,896.76		2,896.76		0.00
	250		01394	30Nov00		1620	Laptop — Dell Lattitude C600 Laptops		4,250.14		4,250.14		0.00
	290		01259	31Jan01		1620	Laptop — Lattitude C600 700 MHZ		2,674.01		2,674.01		0.00
	407		01705	12Sep01		1620	Infocus LP130 Prem Digital Projector		4,476.05		4,476.05		0.00
	503		2394	31Mar02		1620	PowerEdge 2550, Pentium, 1.4 GHz, 512K Cache Server		4,587.95		4,587.95		0.00
	504		01812	31Mar02		1620	244131, 3CO-3C17700-US, 3COM Switches		5,027.96		5,027.96		0.00
	555		01857	02May02		1620	Avocent DSR2161 2/U DIG-1/U LOCAL 16 KVM Hardware		4,699.65		4,699.65		0.00
	606		2391	13Jun02		1620	PowerEdge 1650, Pentium III-T, 1.4GHz, 512K Cache, Base Server		5,383.31		5,383.31		0.00
	608		2392	13Jun02		1620	PowerEdge, 1650, Pentium III-T, 1.4GHz, 512K Cache, Base Server		5,383.32		5,383.32		0.00
	610		02435	19Jun02		1620	PowerEdge 2650, 2.2 GHz/512K Cache Xeon Server File 01		4,209.07		4,209.07		0.00
	660		01411	07Aug02		1620	Back Up System — PowerVault 128T, 5U, Rack, 1 Drive, LTO		10,654.57		10,654.57		0.00
	700		2393	23Oct02		1620	PowerEdge 1650, Pentium, III-T, 1.4GHz, 512K Cache Base Server		5,095.04		5,095.04		0.00
	747		02060	15Jan03		1620	PowerEdge 2650, 1.8GHz/512K Server		4,587.95		4,587.95		0.00
	767		02126-1	26Feb03		1620	Infocus LP790HB Projector 3300 Lumen XGA		5,454.17		5,454.17		0.00
	915		01942	25Sep03		1620	Laptop — Latitude D400, 1.70GHz, Pen M.		3,098.11		3,098.11		0.00
	917		01943	25Sep03		1620	Laptop -Latitude D400, 1.70GHz, PEN M., 12.1 XGA, NIC		3,098.11		3,098.11		0.00
	975		02276	31Dec03		1620	HP Color Laser Jet Printer — 5500DN		3,926.18		3,926.18		0.00
	999		02300	30Jan04		1620	PowerEdge 2650, 3.2GHz/1MB Cache/533MHz FSB Xeon		6,993.03		6,993.03		0.00
	1,000		02301	30Jan04		1620	PowerEdge 2650, 3.2GHz/1MB Cache/533MHz FSB Xeon		6,993.03		6,993.03		0.00
	1,004		02245	28Jan04		1620	Laptop — Latitude D400, 1.70GHz, Pen M.		2,807.55		2,807.55		0.00
	1,008		02304	19Jan04		1620	Apple PM G5/1.8 160GB 512M		4,831.20		4,831.20		0.00
	1,033		02122	12Feb04		1620	Dell Workgroup Laser Printer W5300n		2,087.09		2,087.09		0.00
	1,049		02228	25Mar04		1620	Laptop — Latitude D400, 1.70GHz, PEN M., 12.1XGA		2,795.82		2,795.82		0.00
	1,050		02303	30Mar04		1620	Gateway 840 Storage Enclosure		7,532.05		7,532.05		0.00
	1,058		2263	30Mar04		1620	Firewall Hardware — CISCO PIX 515E Chassis Fail Over		2,828.99		2,828.99		0.00
	1,071		02223	09Apr04		1620	Laptop — Latitude D400, 1.70GHz, PEN M., 12.1 XGA		2,794.59		2,794.59		0.00
	1,121		2299	25Jun04		1620	IT Hardware — Power VAult 136T, LTO-2		26,799.80		26,799.80		0.00
	1,135		2336	14Jul04		1620	PSS 100E Dual Controller		29,729.17		29,729.17		0.00
	1,173		02338	01Nov04		1620	Server — Fre VM03 Poweredge 2650		15,069.43		15,069.43		0.00
	1,185		02339	11Nov04		1620	HP Procurve Switch — Network Equipment		5,167.18		5,167.18		0.00
	1,266		2428	19Feb06		1620	Laptop Sony TX650P		2,542.86		2,542.86		0.00
	1,269		2430	13Apr06		1620	Dell PowerEdge 1850 S/T 1CSCR91		4,292.72		4,173.48		119.24
	1,270		2429	13Apr06		1620	Dell PowerEdge 1850 S/T FYTCR91		6,085.14		5,916.10		169.04
	1,271		2431	30Apr06		1620	Cisco Pix 515E Chassis Failover		2,557.32		2,344.21		213.11
	1,295			27Dec06		1620	Latitude D420 ST: JZB96C1		2,084.74		1,563.54		521.20


									219,287.58		218,264.99		1,022.59
	359		N/A	01May01		1621	5-User MAS200 Licenses		6,480.00		6,480.00		0.00
	472		N/A	21Feb02		1621	MAS Window Work Order Processing & MAS90 MRP Software		4,726.88		4,726.88		0.00
	605		N/A	17Jun02		1621	5-User License for MAS200		6,495.00		6,495.00		0.00
	679		02009	10Sep02		1621	TN-2224B 24-Port Digital 2W-Ref Software		2,830.84		2,830.84		0.00
	722		N/A	30Nov02		1621	Prophix Software for Budget		20,357.07		20,357.07		0.00
	748		N/A	16Jan03		1621	5 User License MAS200 CS		6,507.00		6,507.00		0.00
	872		N/A	08May03		1621	5 User License MAS200 CS		6,495.00		6,495.00		0.00
	932		N/A	30Sep03		1621	MCF SAV CUP 251-500 Software		4,391.16		4,391.16		0.00
	933		N/A	30Sep03		1621	MCL ACS UPG PERP 251-500 Software		6,448.45		6,448.45		0.00


System		Asset		Acquisition				Acquisition		Accumulated
Number		Tag		Date	Account		Description	Value		Depreciation		Net Book Value
	1,005		N/A	21Jan04		1621	VMWARE GSX SERVER 2 CPU V2.5 WIN EMA Software		3,088.37		3,088.37		0.00
	1,038		N/A	28Feb04		1621	VMWARE GSX Server CPU V2.5 Win EMA Software		2,853.00		2,853.00		0.00
	1,107	NA		31May04		1621	Windows Svr Std English SA MVL Licenses		121,687.07		121,687.07		0.00
	1,175			01Nov04		1621	Titanium SQL Software		3,750.00		3,750.00		0.00
	1,272			31May06		1621	SBE BES TO ENTPR BES 4.1 UPGRADE		2,773.77		2,619.68		154.09


									198,883.61		198,729.52		154.09
	331		01477	31Mar01		1630	HON File Cabinets		3,152.06		3,152.06		0.00
	354		01477-A	30Apr01		1630	HON File Cabinets for Accounting		4,281.72		4,281.72		0.00
	357		01477-B	30Apr01		1630	HON File Cabinets for Accounting		6,410.46		6,410.46		0.00
	518		N/A	01Mar02		1630	3 Creative Wood 72" Credenzas		3,989.41		3,989.41		0.00
	805		N/A	30Apr03		1630	13 8X8 Cubicles and 7 10X12 Cubicles		7,169.60		7,169.60		0.00
	1,294			02Dec06		1630	Lateral 3 drawer 43" Fire Resistant		2,565.41		1,154.43		1,410.98
	1,304			20Feb07		1630	Desk/Credenza		2,347.28		978.03		1,369.25
	1,305			02Feb07		1630	Lateral 4 drawer 43" fire resistant with lock & key		2,695.91		1,168.22		1,527.69
	1,328		02474	07Jan08		1630	Lateral 4 drawer 43" fire resistant with lock & key		2,689.39		672.35		2,017.04


									35,301.24		28,976.28		6,324.96
	1,329		N/A	30Jun08		1640	Electrical Installation		10,550.00		3,956.25		6,593.75
	1,330		N/A	30Jun08		1640	Voice and Data Install		11,887.00		4,457.62		7,429.38
	1,331		N/A	30Jun08		1640	PBX Install		8,709.48		3,266.05		5,443.43
	1,332		N/A	30Jun08		1640	Cubicle Design Service: 12 8x8 and 6 10x12		4,041.00		1,515.37		2,525.63
	1,333		N/A	28Aug08		1640	PBX Install SYSNO 1331-Reduction in Price-Refund		-500.00		-145.83		-354.17


									34,687.48		13,049.46		21,638.02
	443		02111	30Nov01		1650	PBS-II		39,014.19		39,014.19		0.00
	807		02109	22Apr03		1650	Biomek 2000 Workstation		49,217.70		49,217.70		0.00
	884		02251	30Jun03		1650	Autoloader PBSII+3C500TC		3,976.13		3,976.13		0.00
	956		02113	30Nov03		1650	Server		2,385.32		2,385.32		0.00
	1,068		02259	31Mar04		1650	Biomek 2000 w/ProteinChip		46,010.00		46,010.00		0.00
	1,179		02348	01Nov04		1650	PCS4000		41,748.72		41,748.72		0.00
	1,180		02349	01Nov04		1650	PCS4000		41,748.72		41,748.72		0.00
	1,192		02404	31Dec04		1650	Biomek 2000 w/ ProteinChip Biomarker		46,762.50		46,762.50		0.00
	1,296		02456	31Dec06		1650	Protein Chip System PCS 4000		39,587.57		39,587.57		0.00
	1,299		02458	31Dec06		1650	Protein Chip System PCS 4000		43,176.27		43,176.27		0.00
	1,300		02459	31Dec06		1650	Protein Chip System PCS 4000		43,176.27		43,176.27		0.00
	1,301		02461	31Dec06		1650	Biomek 2000 w/ ProteinChip Biomarker		43,000.00		43,000.00		0.00
	1,302		02462	31Dec06		1650	Biomek 2000 w/ ProteinChip Biomarker		43,000.00		43,000.00		0.00
	1,303			31Dec06		1650	Autoloader		3,443.94		3,443.94		0.00
	1,310			01Mar07		1650	Sales tax for Dec06 inventory trf #1296,1297,1299,1300,1301,1302,1303		22,624.03		22,624.03		0.00


									508,871.36		508,871.36		0.00


							Grand Total:		2,962,643.96		2,447,205.89		515,438.07

B6D (Official Form 6D) (12/07)

SCHEDULE D — CREDITORS HOLDING SECURED CLAIMS

State the name, mailing address, including zip code, and last four digits of any account number of all entities holding claims secured by property of the debtor as of the date of filing of the petition. The complete account number of any account the debtor has with the creditor is useful to the trustee and the creditor and may be provided if the debtor chooses to do so. List creditors holding all types of secured interests such as judgment liens, garnishments, statutory liens, mortgages, deeds of trust, and other security interests.

List creditors in alphabetical order to the extent practicable. If a minor child is the creditor, state the child’s initials and the name and address of the child’s parent or guardian, such as “A.B., a minor child, by John Doe, guardian.” Do not disclose the child’s name. See, 11 U.S.C. §112 and Fed R. Bankr. P. 1007(m). If all secured creditors will not fit on this page, use the continuation sheet provided.

If the claim is contingent, place an “X” in the column labeled “Contingent.” If the claim is unliquidated, place an “X” in the column labeled “Unliquidated.” If the claim is disputed, place an “X” in the column labeled “Disputed.” (You may need to place an “X” in more than one of these three columns).

Total the columns labeled “Amount of Claim Without Deducting Value of Collateral” and “Unsecured Portion, if Any” in the boxes labeled “Total(s)” on the last sheet of the completed schedule. Report the total from the column labeled “Amount of Claim Without Deducting Value of Collateral” also on the Summary of Schedules and, if the debtor is an individual with primarily consumer debts, report the total from the column labeled “Unsecured Portion, if Any” on the Statistical Summary of Certain Liabilities and Related Data.

o Check this box if debtor has no creditors holding secured claims to report on this Schedule D.

Husband, Wife, Joint or Community

CREDITOR’S NAME AND

DATE CLAIM WAS INCURRED,

MAILING ADDRESS

NATURE OF LIEN, AND

AMOUNT OF CLAIM

INCLUDING ZIP CODE AND

DESCRIPTION AND VALUE

WITHOUT

UNSECURED

AN ACCOUNT NUMBER

OF PROPERTY

DEDUCTING VALUE

PORTION,

(See Instructions Above)

CODEBTOR

HWJC

SUBJECT TO LIEN

CONTINGENT

UNLIQUIDATED

DISPUTED

OF COLLATERAL

IF ANY

ACCOUNT NO.

Quest Diagnostics, Inc.
3 Giralda Farms
Madison, NJ 07940

Research and development Loan. Credit Agreement entered on July 22, 2005

VALUE

$0.00

$10,000,000.00

10,000,000.00

Total(s)

$10,000,000.00

10,000,000.00

(Use only on last page)

(Report also on Summary of Schedules)

If applicable, report also on Statistical Summary of Certain Liabilities and Related Data)

Sheet 1 of 1 total sheets in Schedule of Creditors Holding Secured Claims


Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


B6E (Official Form 6E) (12/07)
In re	Vermillion, Inc.		Case No.	09-11091

		Debtor(s)

SCHEDULE E — CREDITORS HOLDING UNSECURED PRIORITY CLAIMS

A complete list of claims entitled to priority, listed separately by type of priority, is to be set forth on the sheets provided. Only holders of unsecured claims entitled to priority should be listed in this schedule. In the boxes provided on the attached sheets, state the name, mailing address, including zip code, and last four digits of the account number, if any, of all entities holding priority claims against the debtor or the property of the debtor, as of the date of the filing of the petition. Use a separate continuation sheet for each type of priority and label each with the type of priority.

The complete account number of any account the debtor has with the creditor is useful to the trustee and the creditor and may be provided it he debtor chooses to do so. If a minor child is a creditor, state the child’s initials and the name and address of the child’s parent or guardian, such as “A.B., a minor child, by John Doe, guardian.” Do not disclose the child’s name. See, 11 U.S.C. §112 and Fed. R. Bankr. P. 1007(m).

If any entity other than a spouse in a joint case may be jointly liable on a claim, place an “X” in the column labeled “Codebtor,” include the entity on the appropriate schedule of creditors, and complete Schedule H-Codebtors. If a joint petition is filed, state whether the husband, wife, both of them, or the marital community may be liable on each claim by placing an “H,” “W,” “J,” or “C” in the column labeled “Husband, Wife, Joint, or Community.” If the claim is contingent, place an “X” in the column labeled “Contingent.” If the claim is unliquidated, place an “X” in the column labeled “Unliquidated.” If the claim is disputed, place an “X” in the column labeled “Disputed.” (You may need to place an “X” in more than one of these three columns.)

Report the total of claims listed on each sheet in the box labeled “Subtotals” on each sheet. Report the total of all claims listed on this Schedule E in the box labeled “Total” on the last sheet of the completed schedule. Report this total also on the Summary of Schedules.

Report the total of amounts entitled to priority listed on each sheet in the box labeled “Subtotals” on each sheet. Report the total of all amounts entitled to priority listed on this Schedule E in the box labeled “Totals” on the last sheet of the completed schedule. Individual debtors with primarily consumer debts report this total also on the Statistical Summary of Certain Liabilities and Related Data.

Report the total of amounts not entitled to priority listed on each sheet in the box labeled “Subtotals” on each sheet. Report the total of all amounts not entitled to priority listed on this Schedule E in the box labeled “Totals” on the last sheet of the completed schedule. Individual debtors with primarily consumer debts report this total also on the Statistical Summary of Certain Liabilities and Related Data.

Check this box if debtor has no creditors holding unsecured priority claims to report on this Schedule E.

TYPES OF PRIORITY CLAIMS (Check the appropriate box(es) below if claims in that category are listed on the attached sheets)

o Domestic Support Obligations

Claims for domestic support that are owed to or recoverable by a spouse, former spouse, or child of the debtor, or the parent, legal guardian, or responsible relative of such a child, or a governmental unit to whom such a domestic support claim has been assigned to the extent provided in 11 U.S.C. § 507(a)(1).

o Extensions of credit in an involuntary case

Claims arising in the ordinary course of the debtor’s business or financial affairs after the commencement of the case but before the earlier of the appointment of a trustee or the order for relief. 11 U.S.C. § 507(a)(3).

þ Wages, salaries, and commissions

Wages, salaries, and commissions, including vacation, severance, and sick leave pay owing to employees and commissions owing to qualifying independent sales representatives up to $10,950* per person earned within 180 days immediately preceding the filing of the original petition, or the cessation of business, whichever occurred first, to the extent provided in 11 U.S.C. § 507(a)(4).


Name	Address	Type	Amount
Gail Page	REDACTED	Severance	$	10,950

Simon Shorter	REDACTED	Severance	$	10,950

Qun Zhou	REDACTED	Severance	$	10,950

Sue Carruthers	REDACTED	Severance	$	5,447

Sheet 1 of 2 total sheets in Schedule of
Creditors Holding Unsecured Priority Claims



Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


B6E (Official Form 6E) (12/07) — Cont.
In re	Vermillion, Inc.		Case No.	09-11091

		Debtor(s)

SCHEDULE E — CREDITORS HOLDING UNSECURED PRIORITY CLAIMS
(Continuation Sheet)

o Contributions to employee benefit plans

Money owed to employee benefit plans for services rendered within 180 days immediately preceding the filing of the original petition, or the cessation of business, whichever occurred first, to the extent provided in 11 U.S.C. § 507(a)(5).

o Certain farmers and fishermen

Claims of certain farmers and fishermen, up to 5,400* per farmer or fisherman, against the debtor, as provided in 11 U.S.C. § 507(a)(6).

o Deposits by individuals

Claims of individuals up to $2,425* for deposits for the purchase, lease, or rental of property or services for personal, family, or household use, that were not delivered or provided. 11 U.S.C. § 507(a)(7).

o Taxes and Certain Other Debts Owed to Governmental Units

Taxes, customs duties, and penalties owing to federal, state, and local governmental units as set forth in 11 U.S.C. §507(a)(8).

o Commitments to Maintain the Capital of an Insured Depository Institution

Claims based on commitments to the FDIC, RTC, Director of the Office of Thrift Supervision, Comptroller of the Currency, or Board of Governors of the Federal Reserve System, or their predecessors or successors, to maintain the capital of an insured depository institution. 11 U.S.C. § 507(a)(9).

o Claims for Death or Personal Injury While Debtor Was Intoxicated

Claims for death or personal injury resulting from the operation of a motor vehicle or vessel while the debtor was intoxicated from using alcohol, a drug, or another substance. 11 U.S.C. § 507(a)(10).


*		Amounts are subject to adjustment on April 1, 2010, and every three years thereafter with respect to cases commenced on or after the date of adjustment.

Sheet 2 of 2 total sheets in Schedule of
Creditors Holding Unsecured Priority Claims



Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


B6F (Official Form 6F) (12/07)
In re	Vermillion, Inc.		Case No.	09-11091

		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS

State the name, mailing address, including zip code, and last four digits of any account number of all entities holding unsecured claims without priority against the debtor, as of the date of filing of the petition. The complete account number of any account the debtor has with the creditor is useful to the trustee and the creditor and may be provided if the debtor chooses to do so. If a minor child is a creditor, state the child’s initials and the name and address of the child’s parent or guardian, such as “A.B., a minor child, by John Doe, guardian.” Do not disclose the child’s name. See 11 U.S.C. §112 and Fed. R. Bankr. P. 1007(m). Do not include claims listed in Schedules D and E. If all creditors will not fit on this page, use the continuation sheet provided.

Report the total of all claims listed on this schedule in the box labeled “Total” on the last sheet of the completed schedule. Report this total also on the Summary of Schedules and, if the debtor is an individual with primarily consumer debts, report this total also on the Statistical Summary of Certain Liabilities and Related Data.

o Check this box if debtor has no creditors holding secured claims to report on this Schedule F.

Husband,

Wife, Joint ,
or

Community

DATE CLAIM WAS

CREDITOR’S NAME,

INCURRED AND

MAILING ADDRESS

CONSIDERATION FOR

INCLUDING ZIP CODE,

CLAIM.

AND ACCOUNT NUMBER

IF CLAIM IS SUBJECT TO

AMOUNT OF

(See instructions above.)

CODEBTOR

HWJC

SETOFF, SO STATE.

CONTINGENT

UNLIQUIDATED

DISPUTED

CLAIM

Airesprings Inc.
PO Box 7420
Van Nuys, CA 91409-7420

Trade debt

4.71

American Express
CPC Remittance Processing
2975W. Corporate Lakes Blvd.
Weston, FL 33331

Trade debt

1,043.47

Applied Clinical Intelligence
225 City Avenue
Suite 15
Bala Cynwyd, PA 19004

Trade debt

220,746.73

AT&T
Payment Center
Sacramento, CA 95887

Trade debt

3,096.08

Sheet 1 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims



Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037	37855	Best Case Bankruptcy


B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091

		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

Husband,

Wife, Joint ,
or

Community

DATE CLAIM WAS

CREDITOR’S NAME,

INCURRED AND

MAILING ADDRESS

CONSIDERATION FOR

INCLUDING ZIP CODE,

CLAIM.

AND ACCOUNT NUMBER

IF CLAIM IS SUBJECT TO

AMOUNT OF

(See instructions above.)

CODEBTOR

HWJC

SETOFF, SO STATE.

CONTINGENT

UNLIQUIDATED

DISPUTED

CLAIM

Baker & McKenzie LLP
One Prudential Plaza Ste #3500
130 East Randolph Drive
Chicago, IL 60601

Trade debt

2,438.17

Beckman Coulter, Inc.
Dept. CH 10164
Palatine, IL 60055

Trade debt

15,000.00

Bio-Rad Laboratories, Inc
Life Science Group
Dept. 9750
Los Angeles, CA 90084

Trade debt

116,507.57

Bioreclamation
P.O. Box 770
Hicksville, NY 11802

Trade debt

6,557.62

Bowne of Los Angeles, Inc
P.O. Box 79358
City of Industry, CA 91716

Trade debt

1,805.00

Bruce & Co.
Attn: Jeff Bruce
20 North Wacker Drive, Ste. 2414
Chicago, IL 60606

4.5% Convertible Senior Notes

135,000.00

Bruce Fund Inc.
Attn: Jeff Bruce
20 North Wacker Drive, Ste. 2414
Chicago, IL 60606

7% Convertible Senior Notes

1,800,000.00

Sheet 2 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims



Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091

		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

Husband,

Wife, Joint ,
or

Community

DATE CLAIM WAS

CREDITOR’S NAME,

INCURRED AND

MAILING ADDRESS

CONSIDERATION FOR

INCLUDING ZIP CODE,

CLAIM.

AND ACCOUNT NUMBER

IF CLAIM IS SUBJECT TO

AMOUNT OF

(See instructions above.)

CODEBTOR

HWJC

SETOFF, SO STATE.

CONTINGENT

UNLIQUIDATED

DISPUTED

CLAIM

Certified Compliance Solutions Inc.
16787 Bernardo Center Drive #A-1
San Diego, CA 92128

Trade debt

6,072.10

CIT Technologies
P.O. Box 100706
Pasadena, CA 91189

Trade debt

336.82

Computer Patent Annuities
CPA House, 11-15 Seaton Place
St. Helier, Jersey JE1 1BL
Channel Islands, Great Britain

Trade debt

4,911.76

Control Solutions
Attn: Accounts Receivable
400 Amherst St. Suite 201
Nashua, NH 03063

Trade debt

4,040.22

Deerfield International Limited
Attn: Robert Olan
780 3rd Avenue
37th Floor
New York, NY 10017

7% Convertible Senior Notes

1,560,000.00

Deerfield Partners, L.P.
Attn: Robert Olan
780 3rd Avenue
37th Floor
New York, NY 10017

7% Convertible Senior Notes

1,440,000.00

Deloitte Tax, LLP
P.O. Box 2079
Carol Stream, IL 60132

Trade debt

107,971.00

Sheet 3 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims



Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091

		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

Husband,

Wife, Joint ,
or

Community

DATE CLAIM WAS

CREDITOR’S NAME,

INCURRED AND

MAILING ADDRESS

CONSIDERATION FOR

INCLUDING ZIP CODE,

CLAIM.

AND ACCOUNT NUMBER

IF CLAIM IS SUBJECT TO

AMOUNT OF

(See instructions above.)

CODEBTOR

HWJC

SETOFF, SO STATE.

CONTINGENT

UNLIQUIDATED

DISPUTED

CLAIM

Edwards Angell Palmer & Dodge LLP
P.O. Box 40956
Hartford, CT 06150

Trade debt

132,318.60

ENDSIGHT
1440 Fourth Street, Suite B
Berkeley, CA 94710

Trade debt

10,125.00

E*Trade Financial
Corporate Services
Attn: Accounts Receivable
P.O. Box 3512
Arlington, VA 22203

Trade debt

8,396.62

Facilities Maintenances Svcs
266 Gifford Avenue
San Jose, CA 95110

Trade debt

329.00

Fedex ERS
P.O. Box 371741
Pittsburgh, PA 15250

Trade debt

246.36

Foley & Lardner
3000 K Street, N.W.
Suite 500
Washington, DC 20007

Trade debt

34,646.56

Gail Page
REDACTED

Severance

353,050.00

Sheet 4 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims



Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091

		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

Husband,

Wife, Joint ,
or

Community

DATE CLAIM WAS

CREDITOR’S NAME,

INCURRED AND

MAILING ADDRESS

CONSIDERATION FOR

INCLUDING ZIP CODE,

CLAIM.

AND ACCOUNT NUMBER

IF CLAIM IS SUBJECT TO

AMOUNT OF

(See instructions above.)

CODEBTOR

HWJC

SETOFF, SO STATE.

CONTINGENT

UNLIQUIDATED

DISPUTED

CLAIM

Global Cross Conferencing
Dept 518
Denver, CO 80291

Trade debt

178.70

Gouffrant, Cecile
REDACTED

Trade debt

1,425.00

Highbridge International LLC
Attn: Eric Colandrea
9 W. 57th Street, 27th Floor
New York, NY 10019

7% Convertible Senior Notes

11,100,000.00

HSBC Bank USA
P.O. Box 5875
Hicksville, NY 11802

Trade debt

14,699.01

Hyman, Phelps & McNamara. P.C
Attn: Accounting
700 13th Street, Suite 1200
Washington, DC 20005

Trade debt

1,400.00

Iron Mountain
P.O. Box 601002
Los Angeles, CA 90060-1002

Trade debt

354.29

John Hopkins University
Attn: Kim Nguyen
John Hopkins Tec. Transfer
100 North Charles St., 5th Floor
Baltimore, MD 21201

Trade debt

323,260.00

Sheet 5 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims



Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091

		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

Husband,

Wife, Joint ,
or

Community

DATE CLAIM WAS

CREDITOR’S NAME,

INCURRED AND

MAILING ADDRESS

CONSIDERATION FOR

INCLUDING ZIP CODE,

CLAIM.

AND ACCOUNT NUMBER

IF CLAIM IS SUBJECT TO

AMOUNT OF

(See instructions above.)

CODEBTOR

HWJC

SETOFF, SO STATE.

CONTINGENT

UNLIQUIDATED

DISPUTED

CLAIM

Landrover Capital
Dept 193901
P.O. Box 55000
Detroit, MI 48355-1939

Trade debt

1,363.77

MD Anderson Cancer Center
Attn: Susan Z. Murray
Office of CME&Conference
1515 Holcombe Blvd.
Houston, TX 77030

Trade debt

28,000.00

Messagelabs, Inc
512 7^th Ave, Six Floor
New York, NY 10018

Trade debt

337.5

Montgomery Professional
Services Corp
File # 031052
P.O. Box 60000
San Francisco, CA 94160

Trade debt

5,760.00

Oaktree Capital Management L.P.
Attn: Andrew Watts
333 South Grand Avenue
26th Floor

Los Angeles, CA 90071

4.5% Convertible Senior Notes

2,365,000.00

Paul, Hastings, Janofsky
1117 S. California Ave
Palo Alto, CA 94304

Trade debt

159,639.18

Sheet 6 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims



Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091

		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

Husband,

Wife, Joint ,
or

Community

DATE CLAIM WAS

CREDITOR’S NAME,

INCURRED AND

MAILING ADDRESS

CONSIDERATION FOR

INCLUDING ZIP CODE,

CLAIM.

AND ACCOUNT NUMBER

IF CLAIM IS SUBJECT TO

AMOUNT OF

(See instructions above.)

CODEBTOR

HWJC

SETOFF, SO STATE.

CONTINGENT

UNLIQUIDATED

DISPUTED

CLAIM

PG & E
P. O. Box 997300
Sacramento, CA 95899

Trade debt

1,368.71

Praxair Distribution, Inc
Dept. LA 21511
Pasadena, CA 91185-1511

Trade debt

24.28

Precision Med. Inc.
132 N. Acacia Avenue
Solana Beach, CA 92075

Trade debt

53,336.09

PricewaterhouseCoopers LLP
P.O. Box 310001-0068
Pasadena, CA 91110

Trade debt

45,000.00

Principal Life Group
PLIC- SBD Grand Island
P.O.Box 10372
Des Moines, IA 50306-0372

Trade debt

197.63

PR. Newswire
G.P.O. Box 5897
New York, NY 10087-5897

Trade debt

1,732

Processworks Inc.
P.O. Box 712748
Cincinatti, OH 45271-2748

Trade debt

50.00

Sheet 7 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims



Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091

		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

Husband,

Wife, Joint ,
or

Community

DATE CLAIM WAS

CREDITOR’S NAME,

INCURRED AND

MAILING ADDRESS

CONSIDERATION FOR

INCLUDING ZIP CODE,

CLAIM.

AND ACCOUNT NUMBER

IF CLAIM IS SUBJECT TO

AMOUNT OF

(See instructions above.)

CODEBTOR

HWJC

SETOFF, SO STATE.

CONTINGENT

UNLIQUIDATED

DISPUTED

CLAIM

Professional Life and Casualty
Attn: Jeff Bruce
20 North Wacker Drive, Ste. 2414

Chicago, IL 60606

7% Convertible Senior Notes

600,000.00

Prologis Limited Partnership — I
4545 Airport Way
Denver, CO 80239

Trade debt

36.45

PurchasePower
P.O. Box 856042
Louisville, Kentucky 40285

Trade debt

206.99

Qun Zhou
REDACTED

Severance

71,450.00

Ross 3, Inc
30514 Knightong Drive
Farmington hills, MI 48331

Trade debt

5,500.00

Sigma-Aldrich Inc.
P.O.Box 535182
Atlanta, GA 30353

Trade debt

1,901.19

Simon Shorter
REDACTED

Severance

142,050.00

Sheet 8 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims



Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091

		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

Husband,

Wife, Joint ,
or

Community

DATE CLAIM WAS

CREDITOR’S NAME,

INCURRED AND

MAILING ADDRESS

CONSIDERATION FOR

INCLUDING ZIP CODE,

CLAIM.

AND ACCOUNT NUMBER

IF CLAIM IS SUBJECT TO

AMOUNT OF

(See instructions above.)

CODEBTOR

HWJC

SETOFF, SO STATE.

CONTINGENT

UNLIQUIDATED

DISPUTED

CLAIM

Sue Carruthers
REDACTED

Severance

25,057.00

ThinkPanmure, LLC
600 Montgomery Street
3rd Floor
San Francisco, CA 94111

Trade debt

77,814.76

Thomson Financial LLC
195 Broadway, 7^th Floor
New York, NY 10007

Trade debt

2,949.00

Townsend and Townsend and Crew
Two Embarcadero Center
8th Floor
San Francisco, CA 94111

Trade debt

90,947.56

U.S. Bank
Attn: Paul Briggs
CM 9705
PO Box 70870

Interest on the 4.5% and 7%

Saint Paul, MN 55170

Convertible Senior Notes

633,750.00

Vision Service Plan ( CA)
P.O. Box 45210
San Francisco, CA 94145

Trade debt

52.74

VWR International Inc.
P.O. Box 31001-1257
Pasadena, CA 91110

Trade debt

25.86

Sheet 9 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims



Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091

		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

Husband,

Wife, Joint ,
or

Community

DATE CLAIM WAS

CREDITOR’S NAME,

INCURRED AND

MAILING ADDRESS

CONSIDERATION FOR

INCLUDING ZIP CODE,

CLAIM.

AND ACCOUNT NUMBER

IF CLAIM IS SUBJECT TO

AMOUNT OF

(See instructions above.)

CODEBTOR

HWJC

SETOFF, SO STATE.

CONTINGENT

UNLIQUIDATED

DISPUTED

CLAIM

Wells Fargo Shareowner Services
P.O. Box 64875
St. Paul, MN 55164

Trade debt

1,404.16

Total

21,749,642.25

See Exhibit for complete trade debt list

(Use only on last page of the completed Schedule F.)
(Report also on Summary of Schedules and, if applicable, on the Statistical
Summary of Certain Liabilities and Related Data.)

Sheet 10 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims



Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037		Best Case Bankruptcy

B6G (Official Form 6G) (12/07)


In re	Vermillion, Inc.		Case No.	09-11091

		Debtor(s)

SCHEDULE G — EXECUTORY CONTRACTS AND UNEXPIRED LEASES

Describe all executory contracts of any nature and all unexpired leases of real or personal property. Include any timeshare interests. State nature of debtor’s interest in contract, i.e., “Purchaser,” “Agent,” etc. State whether debtor is the lessor or lessee of a lease. Provide the names and complete mailing addresses of all other parties to each lease or contract described. If a minor child is a party to one of the leases or contracts, state the child’s initials and the name and address of the child’s parent or guardian, such as “A.B., a minor child, by John Doe, guardian.” Do not disclose the child’s name. See, 11 U.S.C. §112 and Fed. R. Bankr. P. 1007(m).

Check this box if debtor has no executory contracts or unexpired leases.


NAME AND MAILING ADDRESS,		DESCRIPTION OF CONTRACT OR LEASE AND
INCLUDING ZIP CODE,		NATURE OF DEBTOR’S INTEREST. STATE
OF OTHER PARTIES TO LEASE OR CONTRACT.		WHETHER LEASE IS FOR NONRESIDENTIAL
		REAL PROPERTY. STATE CONTRACT
		NUMBER OF ANY GOVERNMENT CONTRACT.

See Schedule G- Exhibit 1

Sheet 1 of 1 total sheets in Schedule of
Executory Contracts and Unexpired Leases



Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037		Best Case Bankruptcy

Schedule G — Exhibit 1


PARTY A	PARTY B	NAME OF AGREEMENT	ADDRESS OF PARTY
ACE Fire Underwriters Insurance Company	Vermillion, Inc.	Workers’ Compensation Insurance	PO Box 31083, Tampa FL 33631

ADP	Ciphergen Biosystems, Inc.	Service Level Agreement	820 N. McCarthy Blvd., Milpitas, CA 95035

Anthem Blue Cross	Vermillion, Inc.	Group Benefit Agreement	P.O. BOX 54630, Los Angeles CA 90054-0630

Applied Clinical Intelligence	Ciphergen Biosystems, Inc.	Consulting Agreement	225 City Avenue, Suite 15, Bala Cynwyd, PA 19004

AT&T Wireless	Ciphergen Biosystems, Inc.	Corporate Agreement to provide telephone services	P.O. BOX 5019, Carol Stream IL 60197-5019

Baker & McKenzie	Ciphergen Biosystems, Inc.	Engagement Letter	One Prudential Plaza, Suite 3500, 130 East Randolph Drive, Chicago, IL 50501-6384

Barkhurst, David	Vermillion, Inc.	Consulting Agreement	REDACTED

Bast, Robert C.	Ciphergen Biosystems, Inc.	Scientific Advisory Board and Diagnostics Consulting Agreement	14 Memorial Point Lane, Houston TX 77024

Baylor College of Medicine	Ciphergen Biosystems, Inc.	Consent Agreement	One Baylor Plaza, Houston, Texas 77030

Bio-Rad Laboratories, Inc.	Ciphergen Biosystems, Inc.	Asset Purchase Agreement	1000 Alfred Nobel Drive, Hercules, CA 04547

Bioreg Technologies, LLC (Rhonda Moe)	Ciphergen Biosystems, Inc.	Consulting Agreement	1022 Ocean Lane, Imperial Beach, CA 91932

Burns, James S.	Ciphergen Biosystems, Inc.	Indemnification Agreement	REDACTED

Carl, Marybeth	Vermillion, Inc.	Consulting Agreement	REDACTED

Carruthers, Susan	Vermillion, Inc.	Consulting Agreement	REDACTED

Certified Compliance Solutions, Inc.	Vermillion, Inc.	Consulting Agreement	16787 Bernardo Center Drive, Suite A-1, San Diego, CA 92128

Chan, Daniel	Ciphergen Biosystems, Inc.	Scientific Advisory Board and Diagnostics Consulting Agreement	REDACTED

Chavez, Jesus	Vermillion, Inc.	Consulting Agreement	REDACTED

Cintas	Ciphergen Biosystems, Inc.	Standard Uniform Rental Service Agreement	P.O. Box 633842, Cincinnati OH 45263-3842

CIT Technology Financing Services, Inc.	Ciphergen Biosystems, Inc.	Lease Agreement on Photocopier	P.O. Box 100706, Pasadena CA 91189-0706

Colorado Prevention Center	Vermillion, Inc.	Master Clinical Services Agreement	789 Shereman Street, Suite 200, Denver CO 80203

Computer Patent Annuities	Ciphergen Biosystems, Inc.	Patent renewal service	CPA House, 11-15 Seaton Place, St. Helier, Jersey JE1 lBL, Channel Islands

Cooke, John P.	Vermillion, Inc.	Consulting Agreement	REDACTED

Schedule G — Exhibit 1


PARTY A	PARTY B	NAME OF AGREEMENT	ADDRESS OF PARTY
Copenhagen University Hospital	Ciphergen Biosystems, Inc.	Amendment 1 to Research and License Agreement Between Clinic of Gynecology and Clinic of Oncology, Rigshospitalet	Nørregade 10, DK-1165 Copenhagen Denmark

Copyright Clearance Center	Ciphergen Biosystems, Inc.	Copyright agreement	222 Rosewood Drive, Danvers MD 01923

Creech, William	Vermillion, Inc.	Consulting Agreement	REDACTED

E*Trade Financial	Ciphergen Biosystems, Inc.	Master Agreement	PO Box 3512, Arlington, VA 22203

EndSight	Ciphergen Biosystems, Inc.	Computer & Network Consulting Services	1440 Fourth Street, Suite B, Berkeley, CA 94710

Federal Insurance Company ( Chubb)	Vermillion, Inc.	Commercial General Liabiltiy Insurance Policy# 35326826	15 Mountain View Road, Warren, NJ 07059

Federal Insurance Company ( Chubb)	Vermillion, Inc.	Worldwide Umbrella Liability Insurance Policy#79217680	15 Mountain View Road, Warren, NJ 07059

Federal Insurance Company ( Chubb)	Vermillion, Inc.	Employment Practice liability Insurance Policy#81468061	15 Mountain View Road, Warren, NJ 07059

Federal Insurance Company ( Chubb)	Vermillion, Inc.	Commercial Automobile Insurance Policy#73240204	15 Mountain View Road, Warren, NJ 07059

Ford, Fiona	Vermillion, Inc.	Consulting Agreement	REDACTED

Harper, Maribeth	Vermillion, Inc.	Consulting Agreement	REDACTED

Health Discovery Corporation	Ciphergen Biosystems, Inc.	Consulting Agreement	2 East Bryan Street, Suite 601, Savannah GEORGIA, 31401

Iron Mountain	Ciphergen Biosystems, Inc.	Agreement for Storage of off-site materials	P.O. BOX 601002, Los Angeles CA 90060-1002

Johns Hopkins University	Molecular Analytical Systems, Inc.	Technology Transfer Agreement	733 North Broadway, Suite 117, Baltimore, MD 21205

Johns Hopkins University	Vermillion, Inc.	Collaborative Agreement Extension	733 North Broadway, Suite 117, Baltimore, MD 21205

Johns Hopkins University	Ciphergen Biosystems, Inc.	Joint Defense Agreement	733 North Broadway, Suite 117, Baltimore, MD 21205

Johns Hopkins University	Ciphergen Biosystems, Inc.	Label License Waiver to Dr. Cotter (replaces voided waiver dated May 27, 2005)	733 North Broadway, Suite 117, Baltimore, MD 21205

Johns Hopkins University	Ciphergen Biosystems, Inc.	Patent and License Agreement	733 North Broadway, Suite 117, Baltimore, MD 21205

Johns Hopkins University, The University of Texas System, The University of Texas M. D. Anderson Cancer Center	Ciphergen Biosystems, Inc.	Research and License Agreement	733 North Broadway, Suite 117, Baltimore, MD 21205

Landess, Tina	Vermillion, Inc.	Consulting Agreement	REDACTED

Leda Consulting	Vermillion, Inc.	Business Development consulting agreement	280 41st Street, Oakland CA 94611

Malloy & Associates	Vermillion, Inc.	Consulting Agreement	354 Whites Landing, Long Beach, CA 90803

Schedule G — Exhibit 1


PARTY A	PARTY B	NAME OF AGREEMENT	ADDRESS OF PARTY
MAS (Baylor College of Medicine)	Ciphergen Biosystems, Inc.	Agreement for the Provision of Executive Search and Consulting Services for CFO	101 First Street, Suite 478, Los Altos, CA 94022

MAS (Illiumesys Pacific)	Molecular Analytical Systems, Inc.	Technology Transfer Agreement	101 First Street, Suite 478, Los Altos, CA 94022

McKool Smith	Ciphergen Biosystems, Inc.	Engagement Agreement	300 Crescent Court, Suite 1500, Dallas, TX 75201

Medmarc Casualty Insurance Company	Vermillion, Inc.	Product Liability Insurance Policy#08CA380082	14280 Park Meadow Drive, Suite 300, Chantilly, VA 20151

Messagelabs	Ciphergen Biosystems, Inc.		512 Seventh Avenue, 6th Floor, NY NY 10018

Messagelabs	Ciphergen Biosystems, Inc.	Customer Agreement	512 Seventh Avenue, 6th Floor, NY NY 10018

Microsoft	Ciphergen Biosystems	Master Agreement	PO Box 810, Buffalo, NY 14207

Microsoft Business	Ciphergen Biosystems, Inc.	Volume Licensing	PO Box 810, Buffalo, NY 14207

Microsoft Select License	Ciphergen Biosystems, Inc.	Contract Agreement	PO Box 810, Buffalo, NY 14207

Molecular Analytical Systems, Inc.	Ciphergen Biosystems, Inc.	Contract Agreement	101 First Street, Suite 478, Los Altos, CA 94022

Morgan Stanley	Ciphergen Biosystems, Inc.	Settlement Agreement	2 Theatre Square, Suite 2/322 Orinda, CA 94563

Morgan Stanley	Ciphergen Biosystems, Inc.	Retirement Plan (401K) Non-Std PS Plan	2 Theatre Square, Suite 2/322 Orinda, CA 94563

Nair & Co.	Ciphergen Biosystems, Inc.	Termination of Administration Agreements	Whitefriars, Lewins Mead, Bristol BS1 2NT, UK

Navigators Insurance Co	Vermillion, Inc.	Directors & Officers Insurance Policy #NY08DOL601993IV	One Penn Plaza, New York, NY 10119

Ohio State University Research Foundation, The	Ciphergen Biosystems, Inc.	Exclusive Cfommercialization License Agreement	1960 Kenny Road, Columbus, OHIO 43210

Ohio State University Research Foundation, The	Ciphergen Biosystems, Inc.	Amendment 1 to Exclusive Commercialization License Agreement	1960 Kenny Road, Columbus, OHIO 43210

Oppenheimer & Co. Inc.	Ciphergen Biosystems, Inc.	Engagement letter — re fairness opinion on terms of sale of assets to Bio-Rad	125 Broad Street, New York, NY 10004

Oppenheimer & Co. Inc.	Ciphergen Biosystems, Inc.	Engagement letter — re Recapitalization and Convertible Promissory Notes	125 Broad Street, New York, NY 10004

Oppenheimer & Co. Inc.	Ciphergen Biosystems, Inc.	Letter entitled “Placement Agent Agreement” — to sell up to $25 Million of Common Stock and Warrants	125 Broad Street, New York, NY 10004

Oppenheimer & Co. Inc. — Individual Employees	Ciphergen Biosystems, Inc.	Letter re Warrants exercisable into 100,000 shares	125 Broad Street, New York, NY 10004

Page, Gail	Vermillion, Inc.	Consulting Agreement	REDACTED

Schedule G — Exhibit 1


PARTY A	PARTY B	NAME OF AGREEMENT	ADDRESS OF PARTY
Page, Gail	Vermillion, Inc.	Severance Agreement	REDACTED

Pallis Communications, Inc. (Kathy C. Pallis)	Vermillion Inc.	Consulting Agreement	87 Encantado Loop, Santa Fe NM 87508
Paul Hastings Janowsky & Walker LLP	Ciphergen Biosystems, Inc.	Corporate Agreement to provide legal services	Five Palo Alto Square, Palo Alto, CA 94306

Praxair Distribution, Inc.	Abiotic Systems, Inc.	Consulting Agreement	Dept LA 21511, Pasadena CA 91185-1511

PrecisionMed International	Ciphergen Biosystems, Inc.	Product Supply Agreement	132 North Acacia Avenue, Solana Beach, CA 92075

PricewaterhouseCoopers	Ciphergen Biosystems, Inc.	Consulting Agreement	Ten Almaden Boulevard, Suite 1600, San Jose, CA 95113

PricewaterhouseCoopers	Ciphergen Biosystems, Ltd.	Engagement Letter	Ten Almaden Boulevard, Suite 1600, San Jose, CA 95113

Prologis Limited Partner	Vermillion, Inc.	Rental Agreement	4545 Airport Way, Denver CO 80239

Public Storage	Vermillion, Inc.	Storage Agreement	42101 Albrae Street, Fremont CA 94538-3123

Quest Diagnostics Incorporated	Ciphergen Biosystems, Inc.	Strategic Alliance Agreement	3 Giralda Farms, Madison, NJ 07940

Quinn Emannuel Urquihart Oliver & Hedges LLP	Vermillion, Inc.	Engagement Letter	50 California Street, 22nd Floor, San Francisco, CA 94111

Sage Software, Inc.	Ciphergen Biosystems, Inc.	Agreement for Accounting System (MAS 90)	PO Box 849887, Dallas, TX 75284-9887

Sheibani, Nadia	Ciphergen Biosystems, Inc.	Consulting Agreement	REDACTED

Shorter, Simon	Vermillion, Inc.	Consulting Agreement	REDACTED

Shorter, Simon	Vermillion, Inc.	Severance Agreement	REDACTED

Silicon Valley Bank	Ciphergen Biosystems, Inc.	Engagement Letter for Legal Services	3005 Tasman Drive, Santa Clara, CA 95054

Smith, Alan	Vermillion, Inc.	Consulting Agreement	REDACTED

Stanford University	Vermillion, Inc.	Exclusive License Agreement	Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305

Stericycle	Ciphergen Biosystems, Inc.	Fee Schedule Agreement	P.O. Box 9001589, Louisville KY 40290-1589

Testorff, Doug	Vermillion, Inc.	Consulting Agreement	REDACTED

Think Panmure	Vermillion, Inc.	Engagement Letter	600 Montgomery Street, 3rd Floor, San Francisco, CA 94111

Schedule G — Exhibit 1


PARTY A	PARTY B	NAME OF AGREEMENT	ADDRESS OF PARTY
Thomson Financial	Ciphergen Biosytems, Inc.	Corporate Services Client Agreement	195 Broadway, New York, NY 10007

Torres, Sarah Lyn	Ciphergen Biosystems, Inc.	Consulting Agreement	REDACTED

University of Kentucky	Ciphergen Biosystems, Inc.	Research and Collaboration Agreement	800 Rose Street, Lexington, Kentucky 40536

University of Texas M.D. Anderson Cancer Center, The	Vermillion, Inc.	Clinical Trial Site Agreement	1515 Holcombe Boulevard, Houston TX 77030

University of Texas M.D. Anderson Cancer Center, The	Ciphergen Biosystems, Inc.	Research and License Agreement	1515 Holcombe Boulevard, Houston TX 77030

University of Texas M.D. Anderson Cancer Center, The	Ciphergen Biosystems, Inc.	Research and License Agreement	1515 Holcombe Boulevard, Houston TX 77030

University of Texas M.D. Anderson Cancer Center, The	Ciphergen Biosystems, Inc.	Research and License Agreement	1515 Holcombe Boulevard, Houston TX 77030

University of Texas Medical Branch	Ciphergen Biosystems, Inc.	Research and License Agreement	301 University Boulevard, Galveston, TX 77555

Vo, Kristy	Vermillion, Inc.	Consulting Agreement	REDACTED

Wallen, William	Ciphergen Biosystems, Inc.	Extension of Term of Scientific Advisory Board & Diagnostic Consulting Agreement	IDEXX Laboratories, Inc. One Idexx Drive, Westbrook, Maine 04092

XL Specialty Insurance Company	Vermillion, Inc.	Excess Directors & Officers Insurance Policy #ELU10711308	Executive Offices, 70 Seaview Avenue, Stamford, CT 06902

Zhou Qun	Vermillion, Inc.	Consulting Agreement	REDACTED

Zhou Qun	Vermillion, Inc.	Severance Agreement	REDACTED

B6H (Official Form 6H) (12/07)


In re	Vermillion, Inc.		Case No.	09-11091

		Debtor(s)

SCHEDULE H — CODEBTORS

Provide the information requested concerning any person or entity, other than a spouse in a joint case, that is also liable on any debts listed by the debtor in the schedules of creditors. Include all guarantors and co-signers. If the debtor resides or resided in a community property state, commonwealth, or territory (including Alaska, Arizona, California, Idaho, Louisiana, Nevada, New Mexico, Puerto Rico, Texas, Washington, or Wisconsin) within the eight years immediately preceding the commencement of this case, identify the name of the debtor’s spouse and of any former spouse who resides or resided with the debtor in the community property state, commonwealth, or territory. Include all names used by the nondebtor spouse during the eight years immediately preceding the commencement of this case. If a minor child is a codebtor or a creditor, state the child’s initials and the name and address of the child’s parent or guardian, such as “A.B., a minor child, by John Doe, guardian.” Do not disclose the child’s name. See, 11 U.S.C. §112 and Fed. R. Bankr. P. 1007(m).

þ Check this box if debtor has no codebtors.


NAME AND ADDRESS OF CODEBTOR		NAME AND ADDRESS OF CREDITOR

Sheet 1 of 1 total sheets in Schedule of Codebtors



Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037		Best Case Bankruptcy

B6 Declaration (Official Form 6-Declaration). (12/07)

United States Bankruptcy Court
District of Delaware


In re	Vermillion, Inc.		Case No.	09-11091

		Debtor(s)	Chapter	11

DECLARATION CONCERNING DEBTOR’S SCHEDULES

DECLARATION UNDER PENALTY OF PERJURY ON BEHALF OF CORPORATION OR PARTNERSHIP

I, the Chair of the Board of Directors of the corporation named as debtor in this case, declare under penalty of perjury that I have read the foregoing summary and schedules, consisting of 45 sheets, and that they are true and correct to the best of my knowledge, information, and belief.



Date June 11, 2009	Signature	/s/ Gail S. Page
		Gail S. Page
		Executive Chairman of the Board of Directors

Penalty for making a false statement or concealing property: Fine of up to $500,000 or imprisonment for up to 5 years or both.

18 U.S.C. §§ 152 and 3571.



Software Copyright (c) 1996-2006 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037		Best Case Bankruptcy


Statement of Financial Affairs and Schedules of Assets and Liabilities		Exhibit 99.2